{
  "query": "days adverse analysis remove",
  "studies": {
    "protocolSection": [
      {
        "identificationModule": {
          "nctId": "NCT02592135",
          "briefTitle": "High Sensitivity cTnT Rules Out Cardiac Insufficiency Trial (TACIT)"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2015-12-21",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2018-05-31",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Heart Failure"
        },
        "designModule": {
          "studyType": "OBSERVATIONAL",
          "enrollmentInfo": {
            "count": 500,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "21 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT03653650",
          "briefTitle": "Autologous Platelet-rich Plasma in the Treatment of Persistent Epithelial Defects"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2018-08-30",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2025-08",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Persistent Epithelial Defect"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 54,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT03306420",
          "briefTitle": "First-in-Human Study of MS201408-0005A as Single Agent and in Combinations"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2017-10-03",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2019-01-14",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Metastatic or Locally Advanced Unresectable Solid Tumors"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 15,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT05414071",
          "briefTitle": "Clinical Investigation of NMS Assist"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2023-12-01",
            "type": "ESTIMATED"
          },
          "completionDateStruct": {
            "date": "2025-03-01",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Parkinson"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 0,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT04952714",
          "briefTitle": "RRT With a Cytokine Absorption Filter (oXiris Â®) in Patients With Septic Shock"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2021-09-01",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2023-11-10",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Acute Kidney Injury", "Septic Shock"]
        },
        "designModule": {
          "studyType": "OBSERVATIONAL",
          "enrollmentInfo": {
            "count": 93,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT03952637",
          "briefTitle": "A Phase 1/2 Study of Intravenous Gene Transfer With an AAV9 Vector Expressing Human Beta-galactosidase in Type I and Type II GM1 Gangliosidosis"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2019-08-19",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2028-01-01",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["Lysosomal Diseases", "Gangliosidosis", "GM1"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 54,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "6 Months",
          "maximumAge": "12 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT00197145",
          "briefTitle": "Study Of Chemokine Coreceptor 5 (CCR5) Antagonist GW873140 In R5-Tropic Treatment-Experienced HIV-Infected Subjects"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2005-07-21",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2007-09-11",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Infection, Human Immunodeficiency Virus I"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 24,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT02028507",
          "briefTitle": "Phase III Palbociclib With Endocrine Therapy vs. Capecitabine in HR+/HER2- MBC With Resistance to Aromatase Inhibitors"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2014-03-13",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2021-01-11",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Metastatic Breast Cancer"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 693,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "FEMALE",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT05581134",
          "briefTitle": "Immersive Virtual Reality in Functional Motor Disorders"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2022-09-29",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2023-09-29",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Functional Motor Disorders"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 36,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT04684563",
          "briefTitle": "huCART19-IL18 in CD19+ Cancers"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2021-05-06",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2036-05",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["Chronic Lymphocytic Leukemia", "Non-hodgkin Lymphoma", "Acute Lymphoblastic Leukemia"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 72,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT04681911",
          "briefTitle": "Inetetamab Combined With Pyrotinib and Chemotherapy in the Treatment of HER2 Positive Metastatic Breast Cancer"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2020-09-09",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2024-09-09",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Breast Cancer"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 71,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "FEMALE",
          "minimumAge": "18 Years",
          "maximumAge": "70 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT06944821",
          "briefTitle": "Effect of in Situ Simulation on Quality of Work Life and Multiprofessional Team Effectiveness in the Intensive Care Unit"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2025-05-19",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2026-12-31",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["Quality of Work Life", "Burn-out", "Simulation"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 100,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": true,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "65 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT04420975",
          "briefTitle": "Nivolumab and BO-112 Before Surgery for the Treatment of Resectable Soft Tissue Sarcoma"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2020-10-14",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2027-01-31",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["Leiomyosarcoma", "Malignant Peripheral Nerve Sheath Tumor", "Myxofibrosarcoma", "Pleomorphic Rhabdomyosarcoma", "Resectable Dedifferentiated Liposarcoma", "Resectable Soft Tissue Sarcoma", "Resectable Undifferentiated Pleomorphic Sarcoma", "Soft Tissue Fibrosarcoma", "Spindle Cell Sarcoma", "Stage I Retroperitoneal Sarcoma AJCC (American Joint Committee on Cancer) v8", "Stage I Soft Tissue Sarcoma of the Trunk and Extremities AJCC v8", "Stage IA Retroperitoneal Sarcoma AJCC v8", "Stage IA Soft Tissue Sarcoma of the Trunk and Extremities AJCC v8", "Stage IB Retroperitoneal Sarcoma AJCC v8", "Stage IB Soft Tissue Sarcoma of the Trunk and Extremities AJCC v8", "Stage II Retroperitoneal Sarcoma AJCC v8", "Stage II Soft Tissue Sarcoma of the Trunk and Extremities AJCC v8", "Stage III Retroperitoneal Sarcoma AJCC v8", "Stage III Soft Tissue Sarcoma of the Trunk and Extremities AJCC v8", "Stage IIIA Retroperitoneal Sarcoma AJCC v8", "Stage IIIA Soft Tissue Sarcoma of the Trunk and Extremities AJCC v8", "Stage IIIB Retroperitoneal Sarcoma AJCC v8", "Stage IIIB Soft Tissue Sarcoma of the Trunk and Extremities AJCC v8", "Storiform-Pleomorphic Malignant Fibrous Histiocytoma", "Synovial Sarcoma", "Undifferentiated High Grade Pleomorphic Sarcoma of Bone", "Undifferentiated Pleomorphic Sarcoma", "Undifferentiated Pleomorphic Sarcoma With Osteoclast-Like Giant Cells", "Undifferentiated Pleomorphic Sarcoma, Inflammatory Variant", "Undifferentiated Spindle Cell Sarcoma"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 14,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT03445065",
          "briefTitle": "A French Study to Evaluate the Usefulness of an Implantable Continuous Glucose Monitoring (CGM) Sensor to Improve Glycemic Control in Participants With Diabetes Mellitus"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2018-02-28",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2020-08-20",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Diabetes Mellitus"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 239,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT04708067",
          "briefTitle": "Hypofractionated Radiation Therapy and Bintrafusp Alfa for the Treatment of Advanced Intrahepatic Cholangiocarcinoma"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2021-08-31",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2027-02-02",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["Locally Advanced Intrahepatic Cholangiocarcinoma", "Metastatic Intrahepatic Cholangiocarcinoma", "Stage III Intrahepatic Cholangiocarcinoma AJCC v8", "Stage IIIA Intrahepatic Cholangiocarcinoma AJCC v8", "Stage IIIB Intrahepatic Cholangiocarcinoma AJCC v8", "Stage IV Intrahepatic Cholangiocarcinoma AJCC v8"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 2,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT04535414",
          "briefTitle": "Phase II Randomized Trial of Bethesda Protocol Compared to Cambridge Method for Detection of Early Stage Gastric Cancer in CDH1 Mutation Carriers"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2023-06-22",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2025-01-10",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Gastric Cancer", "Gastric Neoplasms", "Gastric Adenocarcinoma"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 195,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT03971409",
          "briefTitle": "Avelumab With Binimetinib, Sacituzumab Govitecan, or Liposomal Doxorubicin in Treating Stage IV or Unresectable, Recurrent Triple Negative Breast Cancer"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2019-07-08",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2026-06-30",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["Stage III Breast Cancer", "Stage IIIA Breast Cancer", "Stage IIIB Breast Cancer", "Stage IIIC Breast Cancer", "Stage IV Breast Cancer", "Invasive Breast Carcinoma", "Recurrent Breast Carcinoma", "Triple-Negative Breast Carcinoma", "Unresectable Breast Carcinoma"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 150,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT00390299",
          "briefTitle": "Viral Therapy in Treating Patients With Recurrent Glioblastoma Multiforme"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2006-10-23",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2019-11-30",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Anaplastic Astrocytoma", "Anaplastic Oligodendroglioma", "Mixed Glioma", "Recurrent Glioblastoma"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 23,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT02294734",
          "briefTitle": "An Efficacy Study of GSK2269557 Added to Standard Care in Subjects With an Acute Exacerbation of Chronic Obstructive Pulmonary Disease"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2015-03-31",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2016-04-25",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Pulmonary Disease, Chronic Obstructive"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 126,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "40 Years",
          "maximumAge": "80 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT07223034",
          "briefTitle": "A Study of 177Lu-PSMA-617 in People With Gliomas"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2025-10-27",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2027-10",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["Glioma", "Diffuse Astrocytoma, IDH-Wildtype (Grade 2-4)", "Glioblastoma, IDH-wildtype", "Diffuse Midline Glioma, H3 K27-Altered", "Diffuse Hemispheric Glioma, H3 G34-mutant", "Diffuse Pediatric-type High-grade Glioma, H3-wildtype and IDH-wildtype"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 20,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT01613287",
          "briefTitle": "Proof of Concept Study of IMMUNOadsorption Therapy in Patients With Idiopathic Pulmonary Arterial Hypertension"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2012-06"
          },
          "completionDateStruct": {
            "date": "2013-11",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Idiopathic Pulmonary Arterial Hypertension"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 12,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "80 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT00420004",
          "briefTitle": "A Study for Participants With Major Depression"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2006-12"
          },
          "completionDateStruct": {
            "date": "2008-03",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Major Depressive Disorder"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 469,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "65 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT05900284",
          "briefTitle": "Safety and Feasibility of Metformin for Sepsis Induced AKI"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2023-11-08",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2026-03-01",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["Sepsis", "Septic Shock", "Acute Kidney Injury", "Metformin"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 80,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT02989857",
          "briefTitle": "Study of AG-120 in Previously Treated Advanced Cholangiocarcinoma With IDH1 Mutations (ClarIDHy)"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2017-02-20",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2021-05-17",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Advanced Cholangiocarcinoma", "Metastatic Cholangiocarcinoma"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 187,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT03730012",
          "briefTitle": "A Study of ASP2215 (Gilteritinib) Combined With Atezolizumab in Patients With Relapsed or Treatment Refractory FMS-like Tyrosine Kinase (FLT3) Mutated Acute Myeloid Leukemia (AML)"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2019-06-19",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2021-06-15",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Acute Myeloid Leukemia (AML)", "Acute Myeloid Leukemia With FMS-like Tyrosine Kinase (FLT3) Mutation"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 11,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT05693467",
          "briefTitle": "Preemptive Co-infiltration of Dexamethasone Palmitate With Ropivacaine for Postoperative Pain in Major Spinal Surgery"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2023-03-01",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2023-09-30",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Pain, Postoperative"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 124,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "64 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT04220892",
          "briefTitle": "Pilot Study of Pembrolizumab Combined With Pemetrexed or Abemaciclib for High Grade Glioma"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2020-07-08",
            "type": "ESTIMATED"
          },
          "completionDateStruct": {
            "date": "2020-07-08",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "High Grade Glioma"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 0,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT05520671",
          "briefTitle": "Evaluating TESLA-G, a Gamified, Telegram-delivered, Quizzing Platform for Surgical Education in Medical Students"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2023-05-01",
            "type": "ESTIMATED"
          },
          "completionDateStruct": {
            "date": "2023-06-30",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Surgical Education in Medical Students"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 50,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": true,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "100 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT05129475",
          "briefTitle": "Food Effect Study to Evaluate the Effect of High-Fat Meal on the Relative Bioavailability of PF-07321332 Boosted With Ritonavir in Healthy Adult Participants"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2021-11-12",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2022-01-12",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Healthy Participants"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 12,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": true,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT05458219",
          "briefTitle": "A First-in-human Study of IBI343 in Subjects With Locally Advanced Unresectable or Metastatic Solid Tumors"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2022-10-26",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2027-12-31",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Locally Advanced Unresectable or Metastatic Solid Tumors"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 470,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT06761287",
          "briefTitle": "Optimizing Patient Selection for Surgery Using Pathologic Analysis Following Neoadjuvant Therapy in Locally Advanced Rectal Cancer"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2025-03-28",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2030-12",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Locally Advanced Rectal Cancer (LARC)"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 20,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT01481922",
          "briefTitle": "What Needle Diameter Should Physician Use When They Perform Lumbar Puncture ? A Randomized Controlled Trial"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2011-11"
          },
          "completionDateStruct": {
            "date": "2013-02",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Post-lumbar Puncture Headache", "Backache"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 62,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT01140451",
          "briefTitle": "Extension Study of Ataluren (PTC124) in Cystic Fibrosis"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2010-08-12",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2013-12-02",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Cystic Fibrosis"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 191,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "6 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT03217253",
          "briefTitle": "Tazemetostat in Treating Patients With Metastatic or Unresectable Solid Tumors or B-Cell Lymphomas With Liver Dysfunction"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2018-03-16",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2019-09-19",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Ann Arbor Stage III B-Cell Non-Hodgkin Lymphoma", "Ann Arbor Stage IV B-Cell Non-Hodgkin Lymphoma", "Metastatic Malignant Solid Neoplasm", "Stage III Hepatocellular Carcinoma AJCC v7", "Stage IIIA Hepatocellular Carcinoma AJCC v7", "Stage IIIB Hepatocellular Carcinoma AJCC v7", "Stage IIIC Hepatocellular Carcinoma AJCC v7", "Stage IV Hepatocellular Carcinoma AJCC v7", "Stage IVA Hepatocellular Carcinoma AJCC v7", "Stage IVB Hepatocellular Carcinoma AJCC v7", "Unresectable Solid Neoplasm"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 0,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT06977165",
          "briefTitle": "Investigating the Impact of Sepsis Phenotypes on Antibiotic Treatment in Patients With Severe Pneumonia and Sepsis"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2025-09-01",
            "type": "ESTIMATED"
          },
          "completionDateStruct": {
            "date": "2027-09-30",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["Respiration Disorders", "Respiratory Failure", "Sepsis", "Infection in ICU", "Pneumonia"]
        },
        "designModule": {
          "studyType": "OBSERVATIONAL",
          "enrollmentInfo": {
            "count": 119,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT03941236",
          "briefTitle": "Extension Trial Evaluating the Long-term Safety and Efficacy of Dasiglucagon in Children With Congenital Hyperinsulinism"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2019-05-01",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2026-12-31",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Congenital Hyperinsulinism"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 44,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "6 Weeks",
          "maximumAge": "13 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT03310957",
          "briefTitle": "Safety and Efficacy of SGN-LIV1A Plus Pembrolizumab for Patients With Locally-Advanced or Metastatic Triple-Negative Breast Cancer"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2018-02-27",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2024-09-30",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Triple Negative Breast Neoplasms"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 185,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT02720367",
          "briefTitle": "Safety and Tolerability of TAR-200 mg in Subjects With Non-Muscle-Invasive Bladder Cancer"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2016-01",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2020-03",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Urinary Bladder Cancer"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 12,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT05663892",
          "briefTitle": "Drug-Drug Interaction Study in Trans Women Living With HIV"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2022-11-23",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2025-01",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["Hiv", "Transgenderism"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 45,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT06555744",
          "briefTitle": "A Study of ZW191 in Participants With Solid Tumors"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2024-10-30",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2027-01",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Advanced Solid Tumors"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 145,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT03788083",
          "briefTitle": "Intratumoral TriMix Injections in Early Breast Cancer Patients"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2018-11-12",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2024-12-30",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["Breast Cancer Female", "Early-stage Breast Cancer"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 36,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "FEMALE",
          "minimumAge": "18 Years",
          "maximumAge": "85 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT00663702",
          "briefTitle": "Phase IIIB Switching From Intravenous to Subcutaneous Study"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2008-05"
          },
          "completionDateStruct": {
            "date": "2012-01",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Arthritis, Rheumatoid"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 123,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT05174845",
          "briefTitle": "Real Word Evidence With 1L Polyethylene Glycol (PEG)+ Ascorbic Acid in Iberia"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2021-10-01",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2022-03-01",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Colon Cancer", "Colon Disease", "Colon Cleansing"]
        },
        "designModule": {
          "studyType": "OBSERVATIONAL",
          "enrollmentInfo": {
            "count": 13393,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT04385745",
          "briefTitle": "Treatment of Children's Forearm Shaft Fractures With Biodegradable Intramedullary Nailing, Compared With Elastic Stable Intramedullary Nailing"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2019-01-05",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2023-01-01",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Fractures, Bone", "Injury Arm"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 15,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "4 Years",
          "maximumAge": "16 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT02182375",
          "briefTitle": "Effect of BI 201335 Mediated UGT1A1 (Uridine-diphosphate-glucuronosyltransferases) Inhibition in Healthy Volunteers"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2010-01"
          },
          "completionDateStruct": {}
        },
        "conditionsModule": {
          "conditions": "Healthy"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 24,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": true,
          "sex": "ALL",
          "minimumAge": "21 Years",
          "maximumAge": "50 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT02127762",
          "briefTitle": "The Effect of Mindfulness Based Stress Reduction in Patients With Painful Diabetic Peripheral Neuropathy"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2012-09"
          },
          "completionDateStruct": {
            "date": "2016-08",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Diabetes Mellitus", "Type I Diabetes", "Type II Diabetes", "Diabetic Peripheral Neuropathy", "Chronic Pain"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 81,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT02134886",
          "briefTitle": "Erlotinib Hydrochloride in Treating Non-Small Cell Lung Cancer That is Metastatic or Cannot be Removed by Surgery in Patients With HIV Infection"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2014-07"
          },
          "completionDateStruct": {
            "date": "2015-09",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["HIV Infection", "Recurrent Non-Small Cell Lung Carcinoma", "Stage IIIA Non-Small Cell Lung Cancer", "Stage IIIB Non-Small Cell Lung Cancer", "Stage IV Non-Small Cell Lung Cancer"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 48,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT02713373",
          "briefTitle": "Cetuximab and Pembrolizumab in Treating Patients With Colorectal Cancer That is Metastatic or Cannot Be Removed by Surgery"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2016-08-05",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2021-07-20",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Recurrent Colorectal Carcinoma", "Stage IVA Colorectal Cancer", "Stage IVB Colorectal Cancer"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 45,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT01366183",
          "briefTitle": "Chemotherapy Toxicity On Quality of Life in Older Patients With Stage I, Stage II, Stage III, or Stage IV Ovarian Epithelial, Primary Peritoneal Cavity, or Fallopian Tube Cancer"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2011-08-15",
            "type": "ACTUAL"
          },
          "completionDateStruct": {}
        },
        "conditionsModule": {
          "conditions": ["Stage I Ovarian Cancer AJCC v6 and v7", "Stage IA Fallopian Tube Cancer AJCC v6 and v7", "Stage IB Fallopian Tube Cancer AJCC v6 and v7", "Stage IC Fallopian Tube Cancer AJCC v6 and v7", "Stage II Ovarian Cancer AJCC v6 and v7", "Stage IIA Fallopian Tube Cancer AJCC v6 and v7", "Stage IIB Fallopian Tube Cancer AJCC v6 and v7", "Stage IIC Fallopian Tube Cancer AJCC v6 and v7", "Stage III Ovarian Cancer AJCC v6 and v7", "Stage III Primary Peritoneal Cancer AJCC v7", "Stage IIIA Fallopian Tube Cancer AJCC v7", "Stage IIIB Fallopian Tube Cancer AJCC v7", "Stage IIIC Fallopian Tube Cancer AJCC v7", "Stage IV Fallopian Tube Cancer AJCC v6 and v7", "Stage IV Ovarian Cancer AJCC v6 and v7", "Stage IV Primary Peritoneal Cancer AJCC v7"]
        },
        "designModule": {
          "studyType": "OBSERVATIONAL",
          "enrollmentInfo": {
            "count": 290,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "75 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT07302594",
          "briefTitle": "Effects of Oro-esophageal Tubes on Swallowing Function in Ischemic Stroke Survivors"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2025-12-20",
            "type": "ESTIMATED"
          },
          "completionDateStruct": {
            "date": "2026-12",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Dysphagia"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 156,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT04123951",
          "briefTitle": "Home-based Exercise in Renal Transplant Recipients"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2020-01-30",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2027-06-30",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Kidney Transplant; Complications"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 50,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT02427841",
          "briefTitle": "Nab-paclitaxel and Gemcitabine Hydrochloride Followed by Radiation Therapy Before Surgery in Treating Patients With Pancreatic Cancer That Can Be Removed by Surgery"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2016-01-21",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2022-12-12",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Pancreatic Adenocarcinoma", "Resectable Pancreatic Carcinoma"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 20,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT01263145",
          "briefTitle": "MK2206 and Paclitaxel in Treating Patients With Locally Advanced or Metastatic Solid Tumors or Metastatic Breast Cancer"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2011-01-05",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2012-10-19",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Adult Solid Neoplasm", "Recurrent Breast Carcinoma", "Stage IV Breast Cancer"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 34,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT04621695",
          "briefTitle": "Comparison of Rubber Band Ligation and Haemorrhoidectomy in Patients With Symptomatic Haemorrhoids Grade III"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2019-11-25",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2023-11-25",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["Hemorrhoids", "Hemorrhoids, Internal", "PROM", "Rectal Diseases"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 360,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT05707689",
          "briefTitle": "The Impact of Gaming on Functioning Among People With Schizophrenia"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2023-02-06",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2025-01-30",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Psychotic Disorder"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 356,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "60 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT06468189",
          "briefTitle": "Clinical and Neurophysiological Effects of tDCS to Visual and Motor Cortex in Migraine"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2024-03-01",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2025-11",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Migraine"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 80,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "55 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT06321289",
          "briefTitle": "Allogeneic TRAC Locus-inserted CD19-targeting STAR T Cell Therapy in r/r B-NHL"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2024-03-20",
            "type": "ESTIMATED"
          },
          "completionDateStruct": {
            "date": "2027-03-20",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Non-hodgkin Lymphoma,B Cell"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 30,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "75 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT03014674",
          "briefTitle": "A Study to Compare the Pharmacokinetics of Mepolizumab as a Liquid Drug in a Safety Syringe or an Autoinjector Versus Lyophilised Drug"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2017-01-06",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2017-08-11",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Asthma"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 246,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": true,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT03908125",
          "briefTitle": "Post Approval Study of the EversenseÂ® Continuous Glucose Monitoring"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2019-03-19",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2024-02-01",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Diabetes Mellitus", "Diabetes Mellitus, Type 1", "Diabetes Mellitus, Type 2"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 273,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT05418088",
          "briefTitle": "Genetically Engineered Cells (Anti-CD19/CD20/CD22 CAR T-cells) for the Treatment of Relapsed or Refractory Lymphoid Malignancies"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2022-06-30",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2026-07-31",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["Recurrent Acute Lymphoblastic Leukemia", "Recurrent B Acute Lymphoblastic Leukemia", "Recurrent B-Cell Prolymphocytic Leukemia", "Recurrent Chronic Lymphocytic Leukemia", "Recurrent High Grade B-Cell Lymphoma", "Recurrent Indolent Non-Hodgkin Lymphoma", "Recurrent Non-Hodgkin Lymphoma", "Recurrent Transformed Chronic Lymphocytic Leukemia", "Refractory Acute Lymphoblastic Leukemia", "Refractory B Acute Lymphoblastic Leukemia", "Refractory B-Cell Prolymphocytic Leukemia", "Refractory Chronic Lymphocytic Leukemia", "Refractory High Grade B-Cell Lymphoma", "Refractory Indolent Non-Hodgkin Lymphoma", "Refractory Non-Hodgkin Lymphoma", "Refractory Transformed Chronic Lymphocytic Leukemia", "Refactory Childhood Acute Lymphoblastic Leukemia", "Refractory Childhood Non-Hodgkin Lymphoma"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 54,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "2 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT00145470",
          "briefTitle": "12 Week Study of the Safety/Efficacy of Asenapine When Added to Lithium/Valproate in the Treatment of Bipolar Disorder (A7501008 / P05844 / MK-8274-017)"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2005-06-02",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2007-03-22",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Bipolar Disorder"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 326,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT03965325",
          "briefTitle": "FOcUs on Colorectal CAncer oUtcomes: Long-Term Study"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2019-06-07",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2025-06-06",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Colorectal Cancer"
        },
        "designModule": {
          "studyType": "OBSERVATIONAL",
          "enrollmentInfo": {
            "count": 133,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT03630497",
          "briefTitle": "BN201 SAD MAD Study in Healthy Subjects"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2018-05-27",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2019-02-22",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Optic Neuritis", "Optic; Neuritis, With Demyelination"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 48,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": true,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "55 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT03441360",
          "briefTitle": "Study to Assess Safety and Preliminary Activity of Eribulin Mesylate in Pediatric Participants With Relapsed/Refractory Rhabdomyosarcoma (RMS), Non-rhabdomyosarcoma Soft Tissue Sarcoma (NRSTS) and Ewing Sarcoma (EWS)"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2018-04-17",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2022-01-21",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Relapsed/Refractory Rhabdomyosarcoma", "Non-rhabdomyosarcoma Soft Tissue Sarcoma", "Ewing Sarcoma"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 23,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "12 Months",
          "maximumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT05813496",
          "briefTitle": "Phase IV Trial to Evaluate Efficacy of Alpha-Lipoic Acid in Treating Symptomatic Diabetic Polyneuropathy in Egypt"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2022-10-26",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2024-12-11",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Polyneuropathy, Diabetic"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 430,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "64 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT07087561",
          "briefTitle": "Short-Term Nutritional Enhancement Combined With Health Education in Postoperative Colorectal Cancer Patients: A Randomized Controlled Trial"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2024-10-10",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2030-10-10",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["Colorectal Cancer (Diagnosis)", "Malnutrition or Risk of Malnutrition"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 360,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT01519323",
          "briefTitle": "BRIM-P: A Study of Vemurafenib in Pediatric Patients With Stage IIIC or Stage IV Melanoma Harboring BRAFV600 Mutations"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2013-01"
          },
          "completionDateStruct": {
            "date": "2015-12",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Malignant Melanoma"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 6,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "12 Years",
          "maximumAge": "17 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT07234903",
          "briefTitle": "ARC-IM Therapy To Support and Promote Recovery of Ambulatory Functions in People With Subacute and Chronic Spinal Cord Injury"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2026-01",
            "type": "ESTIMATED"
          },
          "completionDateStruct": {
            "date": "2032-01",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["Spinal Cord Injury", "SCI", "SCI - Spinal Cord Injury", "Subacute Spinal Cord Injury", "Chronic Spinal Cord Injury", "Spinal Cord Injury (SCI)"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 12,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "65 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT03250676",
          "briefTitle": "Trial of H3B-6545, in Women With Locally Advanced or Metastatic Estrogen Receptor-positive, HER2 Negative Breast Cancer"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2017-08-23",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2023-10-26",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Breast Neoplasms", "Breast Cancer", "Estrogen-receptor Positive Breast Cancer", "Cancer, Breast", "Breast Cancer Female", "Breast Adenocarcinoma", "Estrogen Receptor Positive Tumor", "ER Positive"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 151,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "FEMALE",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT02345460",
          "briefTitle": "Preoperative Folfirinox for Resectable Pancreatic Adenocarcinoma - A Phase II Study"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2015-09"
          },
          "completionDateStruct": {
            "date": "2016-03",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Pancreatic Adenocarcinoma", "Poorly Differentiated Malignant Neoplasm", "Resectable Pancreatic Cancer", "Stage IA Pancreatic Cancer", "Stage IB Pancreatic Cancer", "Stage IIA Pancreatic Cancer", "Stage IIB Pancreatic Cancer", "Stage III Pancreatic Cancer", "Undifferentiated Pancreatic Carcinoma"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 1,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "75 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT02377362",
          "briefTitle": "A Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of GLWL-01"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2015-03"
          },
          "completionDateStruct": {
            "date": "2016-11-09",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Diabetes Mellitus, Type 2"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 74,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": true,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "70 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT00528866",
          "briefTitle": "Radiation Therapy, Androgen Suppression, and Docetaxel in Treating Patients With High-Risk Prostate Cancer Who Have Undergone Radical Prostatectomy"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2008-04",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2018-05-14",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Prostate Cancer"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 80,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "MALE",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT04644029",
          "briefTitle": "Oral ISL QM as PrEP in Cisgender Women at High Risk for HIV-1 Infection (MK-8591-022)"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2021-02-24",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2024-06-11",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["HIV-I", "Human Immunodeficiency Virus Type 1", "Prophylaxis"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 730,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": true,
          "sex": "FEMALE",
          "minimumAge": "16 Years",
          "maximumAge": "45 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT06352749",
          "briefTitle": "Face-to-face vs Online Physical Exercise in Seniors Living in Nursing Homes (ExerMOT-NH)"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2024-03-18",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2025-11-30",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["Physical Function", "Cognitive Decline", "Psychological Well-Being"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 120,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": true,
          "sex": "ALL",
          "minimumAge": "65 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT04068649",
          "briefTitle": "Single-Fraction SBRT Versus Standard Palliative Radiation Therapy in Treating Patients With Metastatic Cancer"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2019-11-18",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2027-11-18",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Metastatic Malignant Neoplasm"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 1500,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT00568321",
          "briefTitle": "RN624 For Pain Of Post-Herpetic Neuralgia"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2007-12-19",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2009-01-07",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Neuralgia, Postherpetic"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 99,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT05955326",
          "briefTitle": "Study to Assess the Safety and Efficacy of Sovateltide in Patients With Acute Cerebral Ischemic Stroke"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2024-01-08",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2026-03",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Acute Cerebral Ischemia"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 160,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "78 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT03229278",
          "briefTitle": "Trigriluzole With Nivolumab and Pembrolizumab in Treating Patients With Metastatic or Unresectable Solid Malignancies or Lymphoma"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2017-10-03",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2022-10-30",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Lymphoma", "Metastatic Malignant Solid Neoplasm", "Metastatic Melanoma", "Metastatic Renal Cell Cancer", "Recurrent Bladder Carcinoma", "Recurrent Classical Hodgkin Lymphoma", "Recurrent Head and Neck Squamous Cell Carcinoma", "Recurrent Lymphoma", "Recurrent Malignant Solid Neoplasm", "Recurrent Renal Cell Carcinoma", "Stage III Bladder Cancer", "Stage III Lymphoma", "Stage III Non-Small Cell Lung Cancer AJCC v7", "Stage III Renal Cell Cancer", "Stage III Skin Melanoma", "Stage IIIA Non-Small Cell Lung Cancer AJCC v7", "Stage IIIA Skin Melanoma", "Stage IIIB Non-Small Cell Lung Cancer AJCC v7", "Stage IIIB Skin Melanoma", "Stage IIIC Skin Melanoma", "Stage IV Bladder Cancer", "Stage IV Lymphoma", "Stage IV Non-Small Cell Lung Cancer AJCC v7", "Stage IV Renal Cell Cancer", "Stage IV Skin Melanoma", "Stage IVA Bladder Cancer", "Stage IVB Bladder Cancer", "Unresectable Head and Neck Squamous Cell Carcinoma", "Unresectable Solid Neoplasm"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 14,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT05162144",
          "briefTitle": "Proximal Medial Gastriocnemius Recession for Chronic Plantar Fasciitis"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2021-12-15",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2026-03-15",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Chronic Plantar Fasciitis"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 150,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "75 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT02074358",
          "briefTitle": "A Study to Assess the Effects of 2 Prothrombin Complex Concentrates on the Pharmacodynamics of Apixaban in Healthy Adult Subjects"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2014-02"
          },
          "completionDateStruct": {
            "date": "2014-04",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Anticoagulation"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 43,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": true,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "45 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT06124248",
          "briefTitle": "Effectiveness of the RISE Intervention"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2023-11-29",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2027-04",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["Sedentary Behaviour", "Stroke"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 1000,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT01121107",
          "briefTitle": "Left Atrial Pressure Monitoring to Optimize Heart Failure Therapy"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2010-04"
          },
          "completionDateStruct": {
            "date": "2015-04",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Heart Failure"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 486,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT04660136",
          "briefTitle": "Usefulness of Contrast-enhanced Ultrasound (CEUS) in Crohn's Disease Pediatric Patients"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2020-12-01",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2023-03",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Crohn's Disease in Pediatric Patient"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 20,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "2 Years",
          "maximumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT02725411",
          "briefTitle": "Long Term Safety and Efficacy Study of Tanezumab in Japanese Adult Subjects With Chronic Low Back Pain"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2016-05-26",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2019-06-11",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Low Back Pain"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 277,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT02020707",
          "briefTitle": "Nab-Paclitaxel and Bevacizumab in Treating Patients With Unresectable Stage IV Melanoma or Gynecological Cancers"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2014-02-24",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2024-07-18",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Cervical Adenocarcinoma", "Cervical Adenosarcoma", "Cervical Adenosquamous Carcinoma", "Cervical Carcinosarcoma", "Cervical Squamous Cell Carcinoma", "Clinical Stage IV Cutaneous Melanoma AJCC v8", "Endometrial Adenosquamous Carcinoma", "Endometrial Clear Cell Adenocarcinoma", "Endometrial Endometrioid Adenocarcinoma", "Endometrial Mixed Cell Adenocarcinoma", "Endometrial Mucinous Adenocarcinoma", "Endometrial Serous Adenocarcinoma", "Endometrial Undifferentiated Carcinoma", "Fallopian Tube Adenocarcinoma", "Fallopian Tube Carcinosarcoma", "Fallopian Tube Clear Cell Adenocarcinoma", "Fallopian Tube Endometrioid Adenocarcinoma", "Fallopian Tube Mucinous Adenocarcinoma", "Fallopian Tube Serous Adenocarcinoma", "Fallopian Tube Squamous Cell Carcinoma", "Fallopian Tube Transitional Cell Carcinoma", "Fallopian Tube Undifferentiated Carcinoma", "Malignant Female Reproductive System Neoplasm", "Malignant Ovarian Clear Cell Tumor", "Malignant Ovarian Endometrioid Tumor", "Malignant Ovarian Epithelial Tumor", "Malignant Ovarian Mucinous Tumor", "Malignant Peritoneal Neoplasm", "Malignant Solid Neoplasm", "Ovarian Carcinosarcoma", "Ovarian Clear Cell Adenocarcinoma", "Ovarian Endometrioid Adenocarcinoma", "Ovarian High Grade Serous Adenocarcinoma", "Ovarian Mucinous Adenocarcinoma", "Ovarian Serous Adenocarcinoma", "Ovarian Transitional Cell Carcinoma", "Ovarian Undifferentiated Carcinoma", "Platinum-Resistant Fallopian Tube Carcinoma", "Platinum-Resistant Ovarian Carcinoma", "Platinum-Resistant Primary Peritoneal Carcinoma", "Platinum-Sensitive Ovarian Carcinoma", "Primary Peritoneal Carcinosarcoma", "Primary Peritoneal Clear Cell Adenocarcinoma", "Primary Peritoneal Serous Adenocarcinoma", "Primary Peritoneal Transitional Cell Carcinoma", "Primary Peritoneal Undifferentiated Carcinoma", "Unresectable Melanoma", "Uterine Corpus Carcinosarcoma"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 43,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT04493684",
          "briefTitle": "GSK3739937 First-Time-In-Human (FTIH) Study in Healthy Volunteers"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2020-07-31",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2021-08-30",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "HIV Infections"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 91,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": true,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "55 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT07166419",
          "briefTitle": "Anti-CD19/20/22 Chimeric Antigen Receptor T Cells (TriCAR19.20.22 T Cells) for the Treatment of Relapsed or Refractory Non-Hodgkin Lymphoma, Acute Lymphoblastic Leukemia, and Chronic Lymphocytic Leukemia"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2026-02-01",
            "type": "ESTIMATED"
          },
          "completionDateStruct": {
            "date": "2026-12-31",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["Blast Phase Chronic Myeloid Leukemia, BCR-ABL1 Positive", "Recurrent Acute Lymphoblastic Leukemia", "Recurrent Chronic Lymphocytic Leukemia", "Recurrent Chronic Myeloid Leukemia, BCR-ABL1 Positive", "Recurrent Indolent Non-Hodgkin Lymphoma", "Recurrent Lymphoblastic Lymphoma", "Recurrent Non-Hodgkin Lymphoma", "Recurrent Transformed Chronic Lymphocytic Leukemia", "Refractory Acute Lymphoblastic Leukemia", "Refractory Chronic Lymphocytic Leukemia", "Refractory Chronic Myeloid Leukemia, BCR-ABL1 Positive", "Refractory Indolent Non-Hodgkin Lymphoma", "Refractory Lymphoblastic Lymphoma", "Refractory Non-Hodgkin Lymphoma", "Refractory Transformed Chronic Lymphocytic Leukemia"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 24,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT01970865",
          "briefTitle": "A Study Of PF-06463922 An ALK/ROS1 Inhibitor In Patients With Advanced Non Small Cell Lung Cancer With Specific Molecular Alterations"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2014-01-08",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2023-05-24",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "ALK-positive Non Small Cell Lung Cancer (NSCLC) and ROS1-positive NSCLC"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 364,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT07069114",
          "briefTitle": "Prognostic Factors for ACDF With BAK/C in Cervical Disc Disease"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2020-01-01",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2023-12-31",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Cervical Spondylosis"
        },
        "designModule": {
          "studyType": "OBSERVATIONAL",
          "enrollmentInfo": {
            "count": 80,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "36 Years",
          "maximumAge": "75 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT05826314",
          "briefTitle": "Boxing Training, Physical-functional Fitness and Cognitive Performance in Older Adults"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2023-10-17",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2025-08-01",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Healthy People Programs"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 75,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": true,
          "sex": "ALL",
          "minimumAge": "60 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT02577406",
          "briefTitle": "An Efficacy and Safety Study of AG-221 (CC-90007) Versus Conventional Care Regimens in Older Subjects With Late Stage Acute Myeloid Leukemia Harboring an Isocitrate Dehydrogenase 2 Mutation"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2015-12-30",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2024-03-25",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Leukemia, Myeloid", "Isocitrate Dehydrogenase"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 319,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "60 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT06733038",
          "briefTitle": "FOLFOXIRI Plus Bevacizumab With or Without Atezolizumab as 1st Line Treatment of pMMR and IS IC-High Metastatic Colorectal Cancer Patients."
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2024-11-15",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2029-04-01",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Colorectal Cancer"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 238,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "75 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT04989647",
          "briefTitle": "Intermediate Risk Cervical Cancer: Radical Surgery +/- Adjuvant Radiotherapy"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2022-06-10",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2032-12",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Cervical Cancer"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 514,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "FEMALE",
          "minimumAge": "18 Years",
          "maximumAge": "85 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT05348538",
          "briefTitle": "Feasibility Study of the Medication Review With Follow up Service for Patients With Polypharmacy in Swiss Community Pharmacies"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2023-04-01",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2024-09-30",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Chronic Disease"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 162,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT06697327",
          "briefTitle": "Daunorubicin + Cytarabine + Venetoclax in de Novo AML"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2025-02-01",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2026-08-01",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["Leukemia, Myeloid, Acute", "Acute Myeloid Leukemia"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 94,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "59 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT03405441",
          "briefTitle": "A Study to Investigate Safety and Tolerability, Pharmacokinetics and Pharmacodynamics of JNJ-55375515 in Healthy Male Participants"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2018-01-02",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2018-09-04",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Healthy"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 42,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": true,
          "sex": "MALE",
          "minimumAge": "18 Years",
          "maximumAge": "54 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT02132754",
          "briefTitle": "Study of MK-4166 and MK-4166 in Combination With Pembrolizumab (MK-3475) in Participants With Advanced Solid Tumors (MK-4166-001)"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2014-06-27",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2019-07-31",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Solid Tumor"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 116,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT02930902",
          "briefTitle": "Pembrolizumab and Paricalcitol With or Without Chemotherapy in Patients With Pancreatic Cancer That Can Be Removed by Surgery"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2017-02-20",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2023-01-03",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Resectable Pancreatic Carcinoma", "Stage I Pancreatic Cancer AJCC v6 and v7", "Stage IA Pancreatic Cancer AJCC v6 and v7", "Stage IB Pancreatic Cancer AJCC v6 and v7", "Stage II Pancreatic Cancer AJCC v6 and v7", "Stage IIA Pancreatic Cancer AJCC v6 and v7", "Stage IIB Pancreatic Cancer AJCC v6 and v7"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 9,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT03261596",
          "briefTitle": "Mebendazole Study Against Hookworm Infections in Children and Adolescents in Ghana"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2017-09",
            "type": "ESTIMATED"
          },
          "completionDateStruct": {
            "date": "2017-12",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Hookworm Infections"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 0,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "6 Years",
          "maximumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT00927862",
          "briefTitle": "Applying Pharmacogenetic Algorithms to Individualize Dosing of Warfarin"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2008-08"
          },
          "completionDateStruct": {
            "date": "2011-06",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Thromboembolism"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 2415,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      }
    ],
    "protocolSection.1": [
      {
        "identificationModule": {
          "nctId": "NCT02615366",
          "briefTitle": "Tranexamic Acid for Bleeding in Breast Surgery"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2016-02"
          },
          "completionDateStruct": {
            "date": "2019-02",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["Hematoma", "Seroma"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 800,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": true,
          "sex": "FEMALE",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT00780494",
          "briefTitle": "Ph II of Capecitabine, Carboplatin & Bevacizumab for Gastroesophageal Junction & Gastric Carcinoma"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2009-02"
          },
          "completionDateStruct": {
            "date": "2017-12-31",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Stomach Cancer", "Gastric (Stomach) Cancer", "Neoplasm of Cardioesophageal Junction", "Gastrointestinal Stromal Tumor (GIST)"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 35,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT02583269",
          "briefTitle": "Muscadine Grape Skin Extract in Treating Patients With Malignancy That Is Metastatic or Cannot Be Removed by Surgery"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2016-03",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2023-04-24",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Advanced Malignant Neoplasm", "Metastatic Malignant Neoplasm", "Unresectable Malignant Neoplasm"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 24,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT04681729",
          "briefTitle": "Dupilumab for the Treatment of Chronic Inducible Cold Urticaria in Patients Who Remain Symptomatic Despite the Use of H1-antihistamine (LIBERTY-CINDU CUrIADS)"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2020-12-10",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2023-04-20",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Cold Urticaria"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 82,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "12 Years",
          "maximumAge": "80 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT05383651",
          "briefTitle": "Post Market, Prospective Multicenter Observational Study of the Safety and Performance of Bellavista Ventilator"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2023-02-01",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2024-06-30",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Ventilation Therapy; Complications"
        },
        "designModule": {
          "studyType": "OBSERVATIONAL",
          "enrollmentInfo": {
            "count": 350,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "6 Months"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT01559129",
          "briefTitle": "Study of Pomalidomide (CC-4047) to Evaluate Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Effectiveness for Patients With Systemic Sclerosis With Interstitial Lung Disease"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2012-08-09",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2016-11-03",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Scleroderma, Systemic", "Sclerosis, Systemic", "Systemic Scleroderma", "Systemic Sclerosis", "Interstitial Lung Disease"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 23,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "80 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT04431375",
          "briefTitle": "Efficacy of Addition of Fecal Microbiota Transplant (FMT) and Plasma Exchange to Tenofovir in Comparison to Monotherapy With Tenofovir in ACLF-HBV"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2020-06-22",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2022-06-10",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["Acute-On-Chronic Liver Failure", "Hepatitis B"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 70,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "75 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT05888103",
          "briefTitle": "Efficacy and Safety of Inclisiran as Monotherapy in Chinese Adults With Low or Moderate ASCVD Risk and Elevated Low-density Lipoprotein Cholesterol."
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2023-07-11",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2024-10-24",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Primary Hypercholesterolemia or Mixed Dyslipidemia"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 207,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "75 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT04374903",
          "briefTitle": "Hydroxychloroquine in Combination With Sirolimus and Dexamethasone for Treating COVID-19 Patients"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2022-04-01",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2022-04-01",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "COVID-19 Patients"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 0,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT02879305",
          "briefTitle": "Anemia Studies in Chronic Kidney Disease: Erythropoiesis Via a Novel Prolyl Hydroxylase Inhibitor Daprodustat-Dialysis (ASCEND-D)"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2016-09-28",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2020-11-09",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Anaemia", "Aspergillosis, Allergic Bronchopulmonary"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 2964,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "99 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT06572631",
          "briefTitle": "Multi-antigen Specific CD8+ T Cells With Decitabine and Lymphodepleting Chemotherapy for the Treatment of Patients With Relapsed or Refractory AML or MDS Following an Allogeneic Hematopoietic Cell Transplantation From a Matched Donor"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2025-06-07",
            "type": "ESTIMATED"
          },
          "completionDateStruct": {
            "date": "2026-12-12",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["Recurrent Acute Myeloid Leukemia", "Recurrent Myelodysplastic Syndrome", "Refractory Acute Myeloid Leukemia", "Refractory Myelodysplastic Syndrome"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 0,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": true,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT01589094",
          "briefTitle": "Neoadjuvant Dose Dense Gemcitabine and Cisplatin (DD GC) In Patients With Muscle-Invasive Bladder Cancer"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2012-04"
          },
          "completionDateStruct": {
            "date": "2018-08",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Bladder Cancer"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 51,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT05765656",
          "briefTitle": "Effectiveness of a Joint General Practitioner-Pharmacist Intervention on Benzodiazepine Deprescribing in the Elderly"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2023-03-15",
            "type": "ESTIMATED"
          },
          "completionDateStruct": {
            "date": "2025-09-15",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["Primary Care", "Health Plan Implementation", "Benzodiazepine Dependence", "Elderly", "Anxiety", "Deprescribing"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 400,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "65 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT05615480",
          "briefTitle": "Effect of Cerebral Oxygen Saturation Monitoring on POCD of Elderly Patients Undergoing Shoulder Arthroscopy"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2023-05-15",
            "type": "ESTIMATED"
          },
          "completionDateStruct": {
            "date": "2026-06-30",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["Cerebral Oxygen Saturation", "Postoperative Cognitive Function"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 400,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "60 Years",
          "maximumAge": "79 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT04417062",
          "briefTitle": "Olaparib With Ceralasertib in Recurrent Osteosarcoma"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2020-11-24",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2026-06-01",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["Osteosarcoma", "Osteosarcoma Recurrent"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 63,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "12 Years",
          "maximumAge": "40 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT03318783",
          "briefTitle": "Subarachnoid Hemorrhage and Soluble Epoxide Hydrolase Inhibition Trial"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2018-05-02",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2020-01-09",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Subarachnoid Hemorrhage, Aneurysmal", "Delayed Cerebral Ischemia", "Vasospasm, Cerebral", "Endothelial Dysfunction"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 20,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT04025866",
          "briefTitle": "Addition of Aerobic Training to Conventional Rehabilitation After Femur Fracture"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2019-02-13",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2022-01-11",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Intertrochanteric Fractures"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 32,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "65 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT06436261",
          "briefTitle": "Evaluating Procedure Pairing of a Post-Procedure Cream Versus a Comparator in Patients Treated With a Hybrid-Fractional Laser for Facial Rejuvenation"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2021-12-14",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2022-07-01",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Photoaging", "Wrinkle", "Skin Laxity"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 20,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": true,
          "sex": "FEMALE",
          "minimumAge": "35 Years",
          "maximumAge": "65 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT02614794",
          "briefTitle": "A Study of Tucatinib vs. Placebo in Combination With Capecitabine & Trastuzumab in Patients With Advanced HER2+ Breast Cancer"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2016-01-28",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2022-08-11",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "HER2 Positive Breast Cancer"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 612,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT03312907",
          "briefTitle": "A Study to Evaluate the Efficacy and Safety of Belimumab Administered in Combination With Rituximab to Adult Subjects With Systemic Lupus Erythematosus (SLE) - BLISS-BELIEVE"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2018-03-01",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2021-07-07",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Systemic Lupus Erythematosus"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 292,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT01234532",
          "briefTitle": "Entinostat and Anastrozole in Treating Postmenopausal Women With TNBC That Can Be Removed by Surgery"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2010-10"
          },
          "completionDateStruct": {
            "date": "2017-05",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Estrogen Receptor-negative Breast Cancer", "HER2-negative Breast Cancer", "Progesterone Receptor-negative Breast Cancer", "Stage I Breast Cancer", "Stage II Breast Cancer", "Stage IIIA Breast Cancer", "Triple-negative Breast Cancer"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 5,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "FEMALE",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT05549752",
          "briefTitle": "Flecainide Versus Amiodarone in the Cardioversion of Paroxysmal Atrial Fibrillation at the Emergency Department, in Patients With Coronary Artery Disease Without Residual Ischemia"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2023-03-24",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2026-01-30",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["Atrial Fibrillation Paroxysmal", "Coronary Artery Disease Without Residual Ischemia"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 80,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "85 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT05874193",
          "briefTitle": "A Collaborative Community Effort Using Belantamab Mafodotin in Relapsed/Refractory Myeloma"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2025-10",
            "type": "ESTIMATED"
          },
          "completionDateStruct": {
            "date": "2027-10",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Relapsed/Refractory Multiple Myeloma"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 33,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT00119249",
          "briefTitle": "Sorafenib in Treating Patients With Stage III or Stage IV Melanoma That Cannot Be Removed By Surgery"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2005-06"
          },
          "completionDateStruct": {}
        },
        "conditionsModule": {
          "conditions": ["Stage III Melanoma", "Stage IV Melanoma"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 74,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT02940249",
          "briefTitle": "Effects of an Apple Extract on Glycaemia: The GLU-Pomme Study"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2017-01"
          },
          "completionDateStruct": {
            "date": "2018-02",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Prevention of Hyperglycaemia"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 34,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": true,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "70 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT02227238",
          "briefTitle": "Comparative Efficacy and Safety Study of Dolutegravir and Lopinavir/Ritonavir in Second-line Treatment"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2014-12-11",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2022-02-14",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "HIV Infections"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 627,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT03136926",
          "briefTitle": "Screening Anti-Fungal Exposure in Intensive Care Units"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2017-01",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2018-12",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Antifungal Agents"
        },
        "designModule": {
          "studyType": "OBSERVATIONAL",
          "enrollmentInfo": {
            "count": 150,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT07201155",
          "briefTitle": "The Accuracy of Continuous Glucose Monitoring Systems in Critically Ill Patients"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2024-05-01",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2024-10-10",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Hyperglycemia in Critically Ill Patients"
        },
        "designModule": {
          "studyType": "OBSERVATIONAL",
          "enrollmentInfo": {
            "count": 55,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "75 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT06840964",
          "briefTitle": "Effect of Omega 3 in Hypertensive Patients"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2023-03-23",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2024-08-30",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Hypertension", "Dyslipidemia"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 100,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "21 Years",
          "maximumAge": "70 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT01870726",
          "briefTitle": "Safety and Efficacy of INC280 and Buparlisib (BKM120) in Patients With Recurrent Glioblastoma"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2014-01-09",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2016-12-23",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "c-MET Inhibitor; PI3K Inhibitor, PTEN Mutations, Homozygous Del. of PTEN or PTEN Neg. by IHC, c-Met Ampli. by FISH, INC280, BKM120, Buparlisib; Recurrent GBM"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 43,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT01959698",
          "briefTitle": "Carfilzomib, Rituximab, Ifosfamide, Carboplatin, and Etoposide in Treating Patients With Relapsed or Refractory Stage I-IV Diffuse Large B-cell Lymphoma"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2014-04-17",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2025-12-01",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["CD20 Positive", "Recurrent Diffuse Large B-Cell Lymphoma", "Refractory Diffuse Large B-Cell Lymphoma", "Stage I Diffuse Large B-Cell Lymphoma", "Stage II Diffuse Large B-Cell Lymphoma", "Stage III Diffuse Large B-Cell Lymphoma", "Stage IV Diffuse Large B-Cell Lymphoma"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 29,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "75 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT05314998",
          "briefTitle": "Adjuvant Trial in Patients With Resected PDAC Randomized to Allocation of Oxaliplatin- or Gemcitabine-based Chemotherapy by Standard Clinical Criteria or by a Transcriptomic Treatment Specific Stratification Signature"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2025-01-15",
            "type": "ESTIMATED"
          },
          "completionDateStruct": {
            "date": "2031-09-01",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Pancreatic Ductal Adenocarcinoma"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 394,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "79 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT01176604",
          "briefTitle": "Yttrium Y 90 Glass Microspheres in Treating Patients With Unresectable Hepatocellular Carcinoma"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2010-08-04",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2021-04-09",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Stage III Hepatocellular Carcinoma AJCC v8", "Stage IIIA Hepatocellular Carcinoma AJCC v8", "Stage IIIB Hepatocellular Carcinoma AJCC v8", "Stage IV Hepatocellular Carcinoma AJCC v8", "Stage IVA Hepatocellular Carcinoma AJCC v8", "Stage IVB Hepatocellular Carcinoma AJCC v8", "Unresectable Hepatocellular Carcinoma"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 299,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT05082948",
          "briefTitle": "Migration Rates of Sutured vs Non-sutured Esophageal Stent Placement"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2021-07-20",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2023-03-15",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Dysphagia, Esophageal", "Esophageal Cancer"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 46,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "99 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT01770860",
          "briefTitle": "A Test of Different Kinds of Bandages on Healing of Wounds"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2013-01"
          },
          "completionDateStruct": {
            "date": "2013-02",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Wound Healing"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 46,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": true,
          "sex": "ALL",
          "minimumAge": "30 Years",
          "maximumAge": "55 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT00719680",
          "briefTitle": "Extension Study of Subcutaneous Immunoglobulin Human in Patients With Primary Immunodeficiency (PID)"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2008-06"
          },
          "completionDateStruct": {
            "date": "2010-06",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Primary Immune Deficiency"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 21,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "2 Years",
          "maximumAge": "75 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT00617890",
          "briefTitle": "A Study to Determine the Activity of Robatumumab (SCH 717454) in Participants With Relapsed Osteosarcoma or Ewing's Sarcoma (MK-7454-002/P04720)"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2008-02-01",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2013-08-31",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Osteosarcoma", "Sarcoma, Ewing's", "Peripheral Neuroectodermal Tumor"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 219,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "4 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT06976710",
          "briefTitle": "PRIORITY-CONNECT 2 Trial"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2025-10-15",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2028-07-30",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["Colorectal Cancer", "Colorectal Neoplasms"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 564,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT06995274",
          "briefTitle": "Umbilical Cord Blood Therapy in a Child With Eosinophilic Duodenitis and Autism Spectrum Disorder: a Case Study"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2025-06-01",
            "type": "ESTIMATED"
          },
          "completionDateStruct": {
            "date": "2025-12-31",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["Autism Spectrum Disorder", "Eosinophilic Gastrointestinal Disorders"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 1,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "MALE",
          "minimumAge": "4 Years",
          "maximumAge": "4 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT06911008",
          "briefTitle": "MTI-301 for the Treatment of Metastatic or Unresectable and Refractory Solid Cancers"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2025-11-07",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2027-04-09",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["Metastatic Malignant Solid Neoplasm", "Refractory Malignant Solid Neoplasm", "Unresectable Malignant Solid Neoplasm"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 42,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT06698510",
          "briefTitle": "Introduction of Arpraziquantel Treatment for Schistosomiasis Control in Preschool-aged Children in Endemic Areas: A Small-scale Public Health Intervention Study"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2024-11-25",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2026-03",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Schistosomiasis"
        },
        "designModule": {
          "studyType": "OBSERVATIONAL",
          "enrollmentInfo": {
            "count": 18500,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": true,
          "sex": "ALL",
          "minimumAge": "24 Months",
          "maximumAge": "59 Months"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT02181413",
          "briefTitle": "A Study of Oral Ixazomib Citrate (MLN9708) Maintenance Therapy in Participants With Multiple Myeloma Following Autologous Stem Cell Transplant"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2014-07-16",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2023-09-08",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Multiple Myeloma", "Autologous Stem Cell Transplant"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 656,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT00603525",
          "briefTitle": "Investigating Clinical Efficacy of Ofatumumab in Adult Rheumatoid Arthritis (RA) Patients Who Had an Inadequate Response to TNF-Î± Antagonist Therapy"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2008-01"
          },
          "completionDateStruct": {
            "date": "2013-07",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Arthritis, Rheumatoid"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 169,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT01599624",
          "briefTitle": "Stress Resilience Training System"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2012-10"
          },
          "completionDateStruct": {
            "date": "2015-05",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Stress", "Anxiety", "Depression", "PTSD"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 68,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": true,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "65 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT03233724",
          "briefTitle": "Oral Decitabine and Tetrahydrouridine as Epigenetic Priming for Pembrolizumab-Mediated Immune Checkpoint Blockade in Patients With Inoperable, or Unresectable Locally Advanced or Metastatic Non-Small Cell Lung Cancers and Esophageal Carcinomas"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2018-04-11",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2021-10-26",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Carcinoma, Non-Small-Cell Lung", "Lung Cancer", "Non-Small Cell Lung Cancer", "Carcinoma, Esophageal", "Malignant Pleural Mesotheliomas"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 9,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "99 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT05550623",
          "briefTitle": "Pneumatic Tourniquet Versus no Tourniquet in Transfemoral Amputation"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2022-10-10",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2026-09-30",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["Amputation", "Blood Loss"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 124,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT02083679",
          "briefTitle": "Sym004 in Subjects With Stage IV Non-small Cell Lung Cancer"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2014-07"
          },
          "completionDateStruct": {
            "date": "2015-08",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Carcinoma, Non-Small-Cell Lung"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 15,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT05411497",
          "briefTitle": "Genetically Engineered Cells (MUC1-Activated T-Cells) for the Treatment of MUC1 Positive Recurrent or Refractory Multiple Myeloma"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2022-06-20",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2028-08-18",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["Recurrent Plasma Cell Myeloma", "Refractory Plasma Cell Myeloma"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 5,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT01042535",
          "briefTitle": "Vaccine Therapy and 1-MT in Treating Patients With Metastatic Breast Cancer"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2009-12-28",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2018-02-27",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Male Breast Cancer", "Recurrent Breast Cancer", "Stage IV Breast Cancer", "Unspecified Adult Solid Tumor, Protocol Specific"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 44,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT05514717",
          "briefTitle": "A Study of XMT-2056 in Advanced/Recurrent Solid Tumors That Express HER2"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2023-01-24",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2027-04",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["HER2-positive Breast Cancer", "HER2-positive Gastric Cancer", "HER2-positive Non-Small Cell Lung Cancer", "HER2-positive Colorectal Cancer", "HER2-positive Tumors", "HER2 Low Breast Cancer"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 162,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT02156076",
          "briefTitle": "A Blinded Study to Evaluate Effect on Atrial Fibrillation Burden in Patients With Paroxysmal Atrial Fibrillation"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2014-07-25",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2016-06-01",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Paroxysmal Atrial Fibrillation"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 158,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT04315324",
          "briefTitle": "Study to Test OBI-3424 in Patients With T-Cell Acute Lymphoblastic Leukemia (T-ALL) or T-Cell Lymphoblastic Lymphoma (T-LBL)"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2021-02-08",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2028-08-01",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["Recurrent T Acute Lymphoblastic Leukemia", "Refractory T Acute Lymphoblastic Leukemia", "Refractory T Lymphoblastic Lymphoma", "T Lymphoblastic Lymphoma"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 67,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "12 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT02769689",
          "briefTitle": "Methylprednisolone During the Switch Between Natalizumab and Fingolimod"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2019-06-12",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2024-07-20",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Multiple Sclerosis"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 56,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "65 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT02980250",
          "briefTitle": "Multi-Center Study of Different Doses Domperidone in Feeding Intolerance"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2015-11"
          },
          "completionDateStruct": {
            "date": "2017-06",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Feeding Intolerance", "Premature Birth", "Domperidone Overdose", "Gastric Retention"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 118,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "20 Weeks",
          "maximumAge": "35 Weeks"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT05327010",
          "briefTitle": "Testing the Combination of the Anti-cancer Drugs ZEN003694 (ZEN-3694) and Talazoparib in Patients With Advanced Solid Tumors, The ComBET Trial"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2022-11-14",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2026-12-31",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["Advanced Malignant Solid Neoplasm", "Metastatic Malignant Solid Neoplasm", "Unresectable Malignant Solid Neoplasm"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 88,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT01589978",
          "briefTitle": "PROMUS Element Plus US Post-Approval Study"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2012-05"
          },
          "completionDateStruct": {
            "date": "2018-06",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Coronary Artery Disease"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 2681,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT02297126",
          "briefTitle": "A Prospective Trial to Assess Cost and Clinical Outcomes of a Clinical Pharmacogenomic Program"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2015-03",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2019-05-03",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Adverse Drug Reaction"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 4465,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT00915278",
          "briefTitle": "A Safety Study Of A Monoclonal Antibody Against A5B1 Integrin In Solid Tumors"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2009-09"
          },
          "completionDateStruct": {
            "date": "2013-01",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Advanced Non-Hematologic Malignancies"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 33,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT02792985",
          "briefTitle": "Multisensory Stimulation and Enriched Environments During Post-traumatic Amnesia"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2015-08"
          },
          "completionDateStruct": {
            "date": "2017-08",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["Brain Injuries, Traumatic", "Confusional State", "Sensory Motor System Disorder", "Alteration of Cognitive Function"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 20,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "80 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT06412926",
          "briefTitle": "A Study to Learn About How Much Emodepside Gets Absorbed in the Blood and How Food Affects Its Absorption When Given as a New Type of Tablet to Healthy Participants"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2024-05-07",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2024-08-27",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Soil-transmitted Helminth Infection", "Onchocerciasis (River Blindness)"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 14,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": true,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "55 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT04513951",
          "briefTitle": "AVELUMAB and CETUXIMAB and mFOLFOXIRI as Initial Therapy for Unresectable Metastatic Colorectal Cancer Patients"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2020-04-01",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2024-12-31",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Metastatic Colorectal Cancer"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 62,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "75 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT05017545",
          "briefTitle": "Carfilzomib and Belatacept for Desensitization"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2021-12-28",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2028-02-28",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Highly Sensitized Prospective Kidney Transplant Recipients"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 15,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "65 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT04204915",
          "briefTitle": "The Early Valve Replacement in Severe ASYmptomatic Aortic Stenosis Study"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2020-03-10",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2031-04-01",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Aortic Stenosis"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 2844,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT04532892",
          "briefTitle": "A Specialized Nutraceutical for Pre-burnout"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2020-03-03",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2022-11-25",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Burn Out", "Psychological Disturbance"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 100,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": true,
          "sex": "ALL",
          "minimumAge": "30 Years",
          "maximumAge": "65 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT00494234",
          "briefTitle": "Study to Assess The Efficacy and Safety of a PARP Inhibitor For The Treatment of BRCA-positive Advanced Breast Cancer"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2007-06-15",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2022-12-21",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Breast Neoplasms"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 54,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "FEMALE",
          "minimumAge": "18 Years",
          "maximumAge": "130 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT07252856",
          "briefTitle": "Transcultural Digital Solutions in Phase III Cardiac Rehabilitation"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2026-01-05",
            "type": "ESTIMATED"
          },
          "completionDateStruct": {
            "date": "2026-07-31",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["Heart Failure", "Myocardial Infarction"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 306,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT04974047",
          "briefTitle": "Study of Tislelizumab in Participants With Resectable Esophageal Squamous Cell Carcinoma"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2021-08-17",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2024-10-25",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Resectable Esophageal Squamous Cell Carcinoma"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 70,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT04143217",
          "briefTitle": "Open-label Long-Term Safety and Efficacy of SPN-812 (Viloxazine Extended-release Capsule) in Adults With ADHD"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2020-01-23",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2022-12-14",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Attention-Deficit/Hyperactivity Disorder"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 159,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "65 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT03718117",
          "briefTitle": "Descriptive Observational Study ALK-2016-CPHG"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2017-01-03",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2020-07-01",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["NSCLC", "Crizotinib", "ALK Gene Rearrangement or ROS1 Gene Rearrangement"]
        },
        "designModule": {
          "studyType": "OBSERVATIONAL",
          "enrollmentInfo": {
            "count": 73,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT06106789",
          "briefTitle": "A Study of the Clinical Benefit of Tobramycin Inhalation Solution"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2023-04-01",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2024-10-30",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["Bronchiectasis", "Cystic Fibrosis", "Lung Infection"]
        },
        "designModule": {
          "studyType": "OBSERVATIONAL",
          "enrollmentInfo": {
            "count": 1600,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT04613518",
          "briefTitle": "A Study of the Safety, Efficacy, and Biomarker Response of BMS-986165 in Participants With Moderate to Severe Ulcerative Colitis"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2021-03-15",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2023-11-29",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Colitis, Ulcerative"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 38,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "65 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT05639647",
          "briefTitle": "Study of 2 Medicines (Aztreonam and Avibactam) Compared to Best Available Therapy for Serious Gram-negative Infections"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2023-04-18",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2026-08-17",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Gram-negative Bacterial Infections"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 48,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "9 Months",
          "maximumAge": "17 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT06542887",
          "briefTitle": "Black Seed Oil in ADHD"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2024-10-01",
            "type": "ESTIMATED"
          },
          "completionDateStruct": {
            "date": "2025-10-01",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "ADHD"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 60,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "6 Years",
          "maximumAge": "12 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT05952804",
          "briefTitle": "IVIG for Infection Prevention After CAR-T-Cell Therapy"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2024-06-10",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2028-07-31",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Hematologic Malignancies"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 150,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT01493414",
          "briefTitle": "INC424 for Patients With Primary Myelofibrosis, Post Polycythemia Myelofibrosis or Post-essential Thrombocythemia Myelofibrosis."
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2011-08-16"
          },
          "completionDateStruct": {
            "date": "2017-01-26",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Myelofibrosis"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 2233,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT01772004",
          "briefTitle": "Avelumab in Metastatic or Locally Advanced Solid Tumors (JAVELIN Solid Tumor)"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2013-01-31",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2019-12-16",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Solid Tumors"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 1756,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT02625610",
          "briefTitle": "Avelumab in First-Line Maintenance Gastric Cancer (JAVELIN Gastric 100)"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2015-12-24",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2021-06-03",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Unresectable, Locally Advanced or Metastatic, Adenocarcinoma of the Stomach, or of the Gastro Esophageal Junction"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 499,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT03133260",
          "briefTitle": "A Project to Improve the Diagnosis and Prognosis of Myocardial Injury Associated to Non Cardiac Surgery"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2017-05-02",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2021-10-15",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Myocardium; Injury"
        },
        "designModule": {
          "studyType": "OBSERVATIONAL",
          "enrollmentInfo": {
            "count": 800,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "sex": "ALL",
          "minimumAge": "45 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT06641479",
          "briefTitle": "JiAngSu Maternal and INfant HEalth Database"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2020-01-01",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2029-12-31",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["Pregnant Women", "Children"]
        },
        "designModule": {
          "studyType": "OBSERVATIONAL",
          "enrollmentInfo": {
            "count": 1570360,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT03775096",
          "briefTitle": "Adrenergic Blockers for Cardiac Changes in Early Parkinson's Disease (Protocol 53136)"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2019-04-04",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2026-07-01",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["REM Sleep Behavior Disorder", "Pre-motor Parkinson Disease", "Symptomatic Parkinson Disease"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 15,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "50 Years",
          "maximumAge": "85 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT02509117",
          "briefTitle": "First-In-Human Study Of Single And Multiple Ascending Doses Of PF-06751979"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2015-07",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2016-07",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Healthy Subjects"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 55,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": true,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "85 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT06871410",
          "briefTitle": "Genetically Engineered Cells (CD83 CAR T Cells) for the Treatment of Relapsed or Refractory Acute Myeloid Leukemia"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2026-01-15",
            "type": "ESTIMATED"
          },
          "completionDateStruct": {
            "date": "2028-04-01",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["Recurrent Acute Myeloid Leukemia", "Refractory Acute Myeloid Leukemia"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 26,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT03218826",
          "briefTitle": "PI3Kbeta Inhibitor AZD8186 and Docetaxel in Treating Patients Advanced Solid Tumors With PTEN or PIK3CB Mutations That Are Metastatic or Cannot Be Removed by Surgery"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2018-09-24",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2026-10-03",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["Advanced Breast Carcinoma", "Advanced Malignant Solid Neoplasm", "Advanced Prostate Carcinoma", "Anatomic Stage III Breast Cancer AJCC v8", "Anatomic Stage IIIA Breast Cancer AJCC v8", "Anatomic Stage IIIB Breast Cancer AJCC v8", "Anatomic Stage IIIC Breast Cancer AJCC v8", "Anatomic Stage IV Breast Cancer AJCC v8", "Castration-Resistant Prostate Carcinoma", "Metastatic Breast Carcinoma", "Metastatic Malignant Solid Neoplasm", "Metastatic Prostate Carcinoma", "Prognostic Stage III Breast Cancer AJCC v8", "Prognostic Stage IIIA Breast Cancer AJCC v8", "Prognostic Stage IIIB Breast Cancer AJCC v8", "Prognostic Stage IIIC Breast Cancer AJCC v8", "Prognostic Stage IV Breast Cancer AJCC v8", "Stage III Prostate Cancer AJCC v8", "Stage IIIA Prostate Cancer AJCC v8", "Stage IIIB Prostate Cancer AJCC v8", "Stage IIIC Prostate Cancer AJCC v8", "Stage IV Prostate Cancer AJCC v8", "Stage IVA Prostate Cancer AJCC v8", "Stage IVB Prostate Cancer AJCC v8", "Triple-Negative Breast Carcinoma", "Unresectable Solid Neoplasm"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 23,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT03991923",
          "briefTitle": "Non-ischemic Preservation of the Donor Heart in Heart Transplantation"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2020-11-25",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2028-12-31",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Heart Transplantation"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 230,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "70 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT07100626",
          "briefTitle": "In-situ Clinical Trial Assessing Ability to Detect and Monitor Active Caries and Their Remineralization"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2025-08",
            "type": "ESTIMATED"
          },
          "completionDateStruct": {
            "date": "2025-10",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Dental Caries"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 12,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": true,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "85 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT05832515",
          "briefTitle": "AHSCT With Fludarabine and Cyclophosphamide Based Conditioning Regimes in Patients With Multiple Sclerosis"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2020-10-01",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2026-12-01",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Multiple Sclerosis"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 200,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "65 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT04545125",
          "briefTitle": "Optimising the Care and Treatment Pathways for Older Patients Facing Major Gastrointestinal Surgery."
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2020-08-18",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2022-09-01",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["Old Age; Debility", "Gastro-Intestinal Disorder"]
        },
        "designModule": {
          "studyType": "OBSERVATIONAL",
          "enrollmentInfo": {
            "count": 120,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "65 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT05257980",
          "briefTitle": "Evaluation of Four New Ready to Drink Oral Nutritional Supplements: Adult ONS Trial"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2021-09-27",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2026-12-31",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Malnutrition"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 100,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "16 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT02382848",
          "briefTitle": "Effectiveness of Prazosin in Bulimic Patients Experiencing Nightmares Due to PTSD"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2015-07"
          },
          "completionDateStruct": {
            "date": "2018-03-09",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Stress Disorders, Post-Traumatic", "Bulimia Nervosa"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 9,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "FEMALE",
          "minimumAge": "18 Years",
          "maximumAge": "45 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT01042678",
          "briefTitle": "Study of MP0112 Intravitreal Injection in Patients With Diabetic Macular Edema"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2010-02"
          },
          "completionDateStruct": {
            "date": "2010-12",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Diabetic Macular Edema"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 18,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT05879250",
          "briefTitle": "WP1066 and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2024-05-22",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2028-12-27",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["Glioblastoma, IDH-Wildtype", "MGMT-Unmethylated Glioblastoma"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 39,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT01425008",
          "briefTitle": "Study of MLN2480 in Participants With Relapsed or Refractory Solid Tumors Followed by a Dose Expansion in Participants With Metastatic Melanoma"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2011-09-15",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2018-10-16",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Melanoma", "Metastatic Melanoma", "Solid Tumor", "Neoplasm"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 149,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT04735991",
          "briefTitle": "A Real-world Clinical Study of Kapok Initiative"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2020-05-08",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2022-10",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Quality of Life"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 100,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "65 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT04811235",
          "briefTitle": "Optical Monitoring With Near-Infrared Spectroscopy for Spinal Cord Injury Trial"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2022-09-24",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2024-09-30",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["Acute Spinal Cord Injury", "Spinal Cord Injuries"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 10,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "17 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT03573024",
          "briefTitle": "Venetoclax and Azacitidine for Non-Elderly Adult Patients With Acute Myeloid Leukemia"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2018-11-28",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2027-06",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Acute Myeloid Leukemia"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 36,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "59 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT05457959",
          "briefTitle": "Peptide-Pulsed Dendritic Cell Vaccination in Combination With Nivolumab and Ipilimumab for the Treatment of Recurrent and/or Progressive Diffuse Hemispheric Glioma, H3 G34-mutant"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2024-12-01",
            "type": "ESTIMATED"
          },
          "completionDateStruct": {
            "date": "2030-12-01",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Diffuse Hemispheric Glioma, H3 G34-Mutant"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 0,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "13 Years",
          "maximumAge": "60 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT06737822",
          "briefTitle": "Upfront Surgery Vs Induction Chemotherapy Followed By Surgery In Oral Cancers:"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2024-12-20",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2029-10",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["Oral Cancer", "Head and Neck Neoplasms"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 346,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "75 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT01193842",
          "briefTitle": "Vorinostat and Combination Chemotherapy With Rituximab in Treating Patients With HIV-Related Diffuse Large B-Cell Non-Hodgkin Lymphoma or Other Aggressive B-Cell Lymphomas"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2010-10-06",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2022-05-19",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["AIDS-Related Plasmablastic Lymphoma", "AIDS-Related Primary Effusion Lymphoma", "Ann Arbor Stage I Diffuse Large B-Cell Lymphoma", "Ann Arbor Stage I Grade 3 Follicular Lymphoma", "Ann Arbor Stage II Diffuse Large B-Cell Lymphoma", "Ann Arbor Stage II Grade 3 Contiguous Follicular Lymphoma", "Ann Arbor Stage II Grade 3 Non-Contiguous Follicular Lymphoma", "Ann Arbor Stage III Diffuse Large B-Cell Lymphoma", "Ann Arbor Stage III Grade 3 Follicular Lymphoma", "Ann Arbor Stage IV Diffuse Large B-Cell Lymphoma", "Ann Arbor Stage IV Grade 3 Follicular Lymphoma", "HIV Infection", "Plasmablastic Lymphoma", "Primary Effusion Lymphoma", "Recurrent Diffuse Large B-Cell Lymphoma", "Recurrent Grade 3 Follicular Lymphoma"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 107,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT03458728",
          "briefTitle": "Safety, Tolerability, Efficacy and Pharmacokinetics of Copanlisib in Pediatric Patients"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2018-04-30",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2023-02-01",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Relapsed or Refractory Solid Tumors or Lymphoma in Children", "Neuroblastoma", "Osteosarcoma", "Rhabdomyosarcoma", "Ewing Sarcoma"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 31,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "6 Months",
          "maximumAge": "21 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT05265273",
          "briefTitle": "A Study of Nipocalimab in Children Aged 2 to Less Than 18 Years With Generalized Myasthenia Gravis"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2022-07-20",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2026-06-26",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Myasthenia Gravis"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 12,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "2 Years",
          "maximumAge": "17 Years"
        }
      }
    ],
    "protocolSection.2": [
      {
        "identificationModule": {
          "nctId": "NCT05863195",
          "briefTitle": "Testing Pump Chemotherapy in Addition to Standard of Care Chemotherapy Versus Standard of Care Chemotherapy Alone for Patients With Unresectable Colorectal Liver Metastases: The PUMP Trial"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2023-10-19",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2034-06-30",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["Metastatic Colorectal Carcinoma", "Metastatic Malignant Neoplasm in the Liver", "Stage IV Colorectal Cancer AJCC v8", "Unresectable Colorectal Carcinoma"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 408,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT00138177",
          "briefTitle": "Suberoylanilide Hydroxamic Acid, Fluorouracil, Leucovorin, and Oxaliplatin in Treating Patients With Progressive Metastatic or Unresectable Colorectal Cancer or Other Solid Tumors"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2005-07"
          },
          "completionDateStruct": {}
        },
        "conditionsModule": {
          "conditions": ["Recurrent Colon Cancer", "Recurrent Rectal Cancer", "Stage III Colon Cancer", "Stage III Rectal Cancer", "Stage IV Colon Cancer", "Stage IV Rectal Cancer", "Unspecified Adult Solid Tumor, Protocol Specific"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 54,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT03901339",
          "briefTitle": "Study of Sacituzumab Govitecan-hziy Versus Treatment of Physician's Choice in Participants With HR+/HER2- Metastatic Breast Cancer"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2019-05-08",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2023-10-20",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Metastatic Breast Cancer"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 543,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT06970470",
          "briefTitle": "Efficacy of Spinal Orthoses on Mobility in Older Adults With Hyperkyphosis"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2025-06",
            "type": "ESTIMATED"
          },
          "completionDateStruct": {
            "date": "2026-09",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Hyperkyphosis"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 75,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "60 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT00904631",
          "briefTitle": "A Prospective, Open Label, Non Randomized, Clinical Study to Evaluate the Safety and Effectiveness of the Eraser Tattoo Removal Device"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2009-05"
          },
          "completionDateStruct": {
            "date": "2010-08",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Removal of Colors Tattoo (Multiple Colors)"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 20,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": true,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT04175769",
          "briefTitle": "A Nutritional Supplement to Support People With Non-small Cell Lung Cancer"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2022-12-19",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2025-12",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Non-small Cell Lung Cancer"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 9,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT05224141",
          "briefTitle": "Pembrolizumab/Vibostolimab (MK-7684A) or Atezolizumab in Combination With Chemotherapy in First Line Treatment of Extensive-Stage Small Cell Lung Cancer (MK-7684A-008/KEYVIBE-008)"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2022-03-24",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2027-06-07",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Small Cell Lung Carcinoma"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 460,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT01544166",
          "briefTitle": "Gadobutrol Pharmacokinetic and Safety Study in Pediatric Subjects Aged <2 Years (Term Newborn Infants to Toddlers 23 Months of Age Inclusive)"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2012-05-16",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2013-11-28",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Magnetic Resonance Imaging"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 44,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "maximumAge": "2 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT06070337",
          "briefTitle": "H-Guard Pilot Safety Evaluation in Haemodialysis Patients"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2023-10-19",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2024-02-29",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Renal Failure", "Renal Insufficiency", "Renal Disease"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 8,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT05108870",
          "briefTitle": "TheraTÂ® Vectors (Vaccines) Combined With Chemotherapy to Treat HPV16 Head and Neck Cancers"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2024-07-17",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2026-01-01",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["Human Papilloma Virus", "HPV", "HPV Positive Oropharyngeal Squamous Cell Carcinoma", "Head and Neck Cancer"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 98,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT05924191",
          "briefTitle": "Preventive Effect of Photobiomodulation in the Postoperative Period of Extractions of Retained Lower Third Molars"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2023-11-20",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2024-07-20",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["Molar, Third", "Photobiomodulation"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 30,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": true,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "50 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT02268552",
          "briefTitle": "An Open Label Study of LMI070 (Branaplam) in Type 1 Spinal Muscular Atrophy (SMA)"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2015-04-02",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2022-12-29",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Spinal Muscular Atrophy"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 40,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "28 Days",
          "maximumAge": "182 Days"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT03091010",
          "briefTitle": "A Comparison of Fecal Microbiota Transplantation and Steroid Therapy in Patients With Severe Alcoholic Hepatitis."
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2017-04-08",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2020-06-30",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Severe Alcoholic Hepatitis"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 112,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "21 Years",
          "maximumAge": "70 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT06569550",
          "briefTitle": "Fatigue Alleviation Through Neuromodulating Therapy in Multiple Sclerosis"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2024-08-14",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2026-02-01",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["Multiple Sclerosis, Relapsing-Remitting", "Fatigue"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 60,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "55 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT06293326",
          "briefTitle": "A First-in-Human Study to Learn How Well a Bi-Layer Calcium Carbonate Antacid Tablet Works Compared to a Standard, Non-Layered Calcium Carbonate Tablet in Healthy Male Participants"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2024-03-06",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2024-05-15",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Heartburn", "Indigestion", "Stomach Acid Related Symptoms", "Nocturnal Stomach Acid Related Symptoms", "Healthy Volunteers"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 21,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": true,
          "sex": "MALE",
          "minimumAge": "18 Years",
          "maximumAge": "65 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT00835185",
          "briefTitle": "Study of IMC-11F8 in Participants With Colorectal Cancer"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2007-08"
          },
          "completionDateStruct": {
            "date": "2010-10",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Metastatic Colorectal Cancer"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 44,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT05945875",
          "briefTitle": "Evaluating the Use of Dual Imaging Techniques for Detection of Disease in Patients With Head and Neck Cancer"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2023-10-03",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2028-12-31",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["Head and Neck Squamous Cell Carcinoma", "Recurrent Head and Neck Squamous Cell Carcinoma"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 40,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "19 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT06499285",
          "briefTitle": "A Study of Elritercept to Treat Anemia in Adults With Very Low, Low, or Intermediate Risk Myelodysplastic Syndromes (MDS) Who Need Regular Blood Transfusions"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2025-05-06",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2032-05-01",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Myelodysplastic Syndromes"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 225,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT02332850",
          "briefTitle": "Phase Ib Study of SAR650984 in Combination With Carfilzomib for Treatment of Relapsed or Refractory Multiple Myeloma"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2015-01-21",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2025-12-31",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Multiple Myeloma"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 83,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT03068468",
          "briefTitle": "Study of BIIB092 in Participants With Progressive Supranuclear Palsy"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2017-06-01",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2020-02-07",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Supranuclear Palsy, Progressive"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 490,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "41 Years",
          "maximumAge": "86 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT03582618",
          "briefTitle": "CVM-1118 and Sorafenib Combination in Subjects With Advanced Hepatocellular Carcinoma"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2018-07-12",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2022-12-30",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Hepatocellular Carcinoma", "Advanced Cancer"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 12,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT05822440",
          "briefTitle": "A Study to Learn About How Itraconazole Affects the Blood Level of Study Medicine (PF-07817883) in Healthy Adults."
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2023-04-13",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2023-07-10",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Healthy"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 12,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": true,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "65 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT03117855",
          "briefTitle": "Capecitabine and Y-90 Radioembolization in Treating Patients With Advanced Bile Duct Cancer in the Liver That Cannot Be Removed by Surgery"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2016-12"
          },
          "completionDateStruct": {}
        },
        "conditionsModule": {
          "conditions": ["Bile Duct Adenocarcinoma", "Stage III Intrahepatic Cholangiocarcinoma", "Stage IVA Intrahepatic Cholangiocarcinoma", "Stage IVB Intrahepatic Cholangiocarcinoma"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 0,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT03582033",
          "briefTitle": "A Safety Study of SEA-BCMA in Patients With Multiple Myeloma"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2018-11-01",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2023-11-09",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Multiple Myeloma"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 83,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT02855125",
          "briefTitle": "A Randomized Phase 2 Trial of TAS-114 in Combination With S-1 Versus S-1"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2016-08-29",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2017-11-30",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Advanced or Metastatic Non-small Cell Lung Cancer"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 128,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT06856213",
          "briefTitle": "Study of Cetuximab Plus/Minus Weekly Paclitaxel After Progression To First-Line Pembrolizumab Plus Platinum-5FU in Subjects With Recurrent/Metastatic Squamous Cell Carcinoma of the Head and Neck."
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2025-06-18",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2028-10",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Recurrent / Metastatic Head and Neck Squamous Cell Carcinoma"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 65,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT06339450",
          "briefTitle": "Real World Environmental Exposure Study With Healthy and Cystic Fibrosis Subjects"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2025-12-01",
            "type": "ESTIMATED"
          },
          "completionDateStruct": {
            "date": "2027-12-01",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Cystic Fibrosis, Pulmonary"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 16,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": true,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "65 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT03567291",
          "briefTitle": "Evaluation of Safety and Tolerability of Long-term TEV-50717 (Deutetrabenazine) for Treatment of Tourette Syndrome in Children and Adolescents"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2018-05-25",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2020-05-15",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Tourette Syndrome"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 228,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "6 Years",
          "maximumAge": "17 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT07042620",
          "briefTitle": "A Study to Test a New Fluid to Improve the Quality of Images Obtained by Using Sound Waves (Ultrasound) During Surgery"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2025-06",
            "type": "ESTIMATED"
          },
          "completionDateStruct": {
            "date": "2026-03",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["Brain Tumor Adult", "Low Grade Glioma (LGG), High Grade Glioma (HGG)", "Glioblastoma"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 15,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT04581382",
          "briefTitle": "Radiation Therapy, Plasma Exchange, and Immunotherapy (Pembrolizumab or Nivolumab) for the Treatment of Melanoma"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2020-12-14",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2024-10-06",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Melanoma"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 18,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT00122382",
          "briefTitle": "Remission and Joint Damage Progression in Early Rheumatoid Arthritis"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2005-07"
          },
          "completionDateStruct": {
            "date": "2009-02",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Rheumatoid Arthritis"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 1052,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT02577354",
          "briefTitle": "ReActiv8 Implantable Neurostimulation System for Chronic Low Back Pain"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2016-08"
          },
          "completionDateStruct": {
            "date": "2024-01",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Chronic Low Back Pain"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 204,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "22 Years",
          "maximumAge": "75 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT05425927",
          "briefTitle": "Comparative Study of Conventional MR Images With Synthetically Reconstructed MR Images of the Brain"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2022-06-27",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2024-07-31",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Clinical Indication for Brain MRI", "Healthy Volunteers"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 189,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": true,
          "sex": "ALL",
          "maximumAge": "99 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT00217542",
          "briefTitle": "Azacitidine and Recombinant Interferon Alfa-2b in Treating Patients With Stage III or Stage IV Melanoma or Stage IV Kidney Cancer That Cannot Be Removed By Surgery"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2005-07"
          },
          "completionDateStruct": {}
        },
        "conditionsModule": {
          "conditions": ["Recurrent Melanoma", "Recurrent Renal Cell Cancer", "Stage III Melanoma", "Stage IV Melanoma", "Stage IV Renal Cell Cancer"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 42,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT04526951",
          "briefTitle": "TENecteplase in Central Retinal Artery Occlusion Stuy (TenCRAOS)"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2020-10-30",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2025-06-20",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Central Retinal Artery Occlusion"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 81,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT06548802",
          "briefTitle": "Efficacy and Safety of Baricitinib in the Post-intracerebral Hemorrhage Pulmonary Injury"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2024-02-29",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2026-06",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Pulmonary Injury After Intracerebral Hemorrhage"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 100,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT03049345",
          "briefTitle": "Gastric Cancer Sentinel Lymph Node Mapping"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2016-07-01",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2022-09-30",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["Gastric Cancer", "Sentinel Lymph Node", "Early Gastric Cancer"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 40,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT00980343",
          "briefTitle": "GDC-0449 in Treating Patients With Recurrent Glioblastoma Multiforme That Can Be Removed by Surgery"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2010-02"
          },
          "completionDateStruct": {
            "date": "2012-06",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Adult Giant Cell Glioblastoma", "Adult Glioblastoma", "Adult Gliosarcoma", "Recurrent Adult Brain Tumor"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 44,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT02351856",
          "briefTitle": "A Rollover Study of ARRY-371797 in Patients With LMNA-Related Dilated Cardiomyopathy"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2015-02-02",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2020-12-21",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "LMNA-Related Dilated Cardiomyopathy"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 8,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT04680780",
          "briefTitle": "Ketogenic Dietary Interventions in Autosomal Dominant Polycystic Kidney Disease (ADPKD)"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2021-01-10",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2022-08-12",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "ADPKD"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 63,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "60 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT04808427",
          "briefTitle": "Pilot Study to Investigate Magnetic Resonance (MR) Image Guided Focal Therapy in Prostate Cancer"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2023-11-20",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2027-09-01",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Prostate Cancer"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 21,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "MALE",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT01011439",
          "briefTitle": "Phase II Study Of Oral PHA-848125AC In Patients With Thymic Carcinoma"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2010-02-22",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2018-12-17",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Thymic Carcinoma"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 72,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT04508257",
          "briefTitle": "The Effect of a New Infant Formula on Growth and Cognition in Healthy Term Infants"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2020-08-01",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2023-02-28",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Child Development"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 450,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": true,
          "sex": "ALL",
          "minimumAge": "30 Days",
          "maximumAge": "30 Days"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT06671106",
          "briefTitle": "Efficacy of an Amine and Zinc Lactate - Containing Mouthrinse in the Home-based Treatment of Plaque-induced Gingivitis in Adolescents."
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2025-01-07",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2026-12-31",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Gingivitis"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 150,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "12 Years",
          "maximumAge": "14 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT06908733",
          "briefTitle": "Integrating Surgery and Radiotherapy Following Tislelizumab-based Conversion Therapy in N3-Stage III NSCLC"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2025-03-31",
            "type": "ESTIMATED"
          },
          "completionDateStruct": {
            "date": "2029-12-30",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Non-Small Cell Lung Cancer (Stage III)"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 30,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT03579771",
          "briefTitle": "Gemcitabine, Cisplatin, and Nab-Paclitaxel Before Surgery in Patients With High-Risk Liver Bile Duct Cancer"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2018-09-26",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2023-09-16",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Resectable Cholangiocarcinoma", "Stage IB Intrahepatic Cholangiocarcinoma AJCC v8", "Stage II Intrahepatic Cholangiocarcinoma AJCC v8", "Stage III Intrahepatic Cholangiocarcinoma AJCC v8", "Stage IIIA Intrahepatic Cholangiocarcinoma AJCC v8", "Stage IIIB Intrahepatic Cholangiocarcinoma AJCC v8"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 30,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "19 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT07098364",
          "briefTitle": "ST-067 in Combination With CD19-Directed CAR T-Cell Therapy (Liso-cel) in Relapsed/Refractory Large B-Cell Lymphoma"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2026-01-08",
            "type": "ESTIMATED"
          },
          "completionDateStruct": {
            "date": "2043-10-04",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["Recurrent Diffuse Large B-Cell Lymphoma", "Recurrent Diffuse Large B-Cell Lymphoma, Not Otherwise Specified", "Recurrent Grade 3b Follicular Lymphoma", "Recurrent High-Grade B-Cell Lymphoma", "Recurrent Indolent B-Cell Non-Hodgkin Lymphoma", "Recurrent Primary Mediastinal Large B-Cell Lymphoma", "Refractory Diffuse Large B-Cell Lymphoma", "Refractory Diffuse Large B-Cell Lymphoma, Not Otherwise Specified", "Refractory Grade 3b Follicular Lymphoma", "Refractory High-Grade B-Cell Lymphoma", "Refractory Indolent B-Cell Non-Hodgkin Lymphoma", "Refractory Primary Mediastinal Large B-Cell Lymphoma"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 33,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT07243951",
          "briefTitle": "Phase II Clinical Study on the Efficacy and Safety of the Combination of Cadonilimab and Capecitabine in Adjuvant Therapy for Combined Hepatocellular Carcinoma and Intrahepatic Cholangiocarcinoma"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2025-11-28",
            "type": "ESTIMATED"
          },
          "completionDateStruct": {
            "date": "2028-06-30",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["Combined Hepatocellular-cholangiocarcinoma", "Liver Neoplasms"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 75,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "75 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT02496663",
          "briefTitle": "Osimertinib and Necitumumab in Treating Patients With EGFR-Mutant Stage IV or Recurrent Non-small Cell Lung Cancer Who Have Progressed on a Previous EGFR Tyrosine Kinase Inhibitor"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2016-05-11",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2027-06-30",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["Metastatic Lung Non-Small Cell Carcinoma", "Recurrent Lung Non-Small Cell Carcinoma", "Stage IV Lung Cancer AJCC v8"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 138,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT03474107",
          "briefTitle": "A Study to Evaluate Enfortumab Vedotin Versus (vs) Chemotherapy in Subjects With Previously Treated Locally Advanced or Metastatic Urothelial Cancer (EV-301)"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2018-06-27",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2025-11-30",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["Ureteral Cancer", "Urothelial Cancer", "Bladder Cancer"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 608,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT05650606",
          "briefTitle": "Inpatient Rehabilitation and Post-Discharge Outcomes With High Intensity Gait Training (HIGT) of Patients With Stroke"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2023-03-18",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2023-10-11",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Cerebral Vascular Accident"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 2,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "85 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT05640336",
          "briefTitle": "Treatment of Acute Periprosthetic Joint Infection Comparing Single and Planned Double-Debridement Antibiotics and Implant Retention Followed by Chronic Antibiotic Suppression"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2023-03-03",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2032-03",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Periprosthetic Joint Infection"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 490,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT04900064",
          "briefTitle": "Evaluation of Primary Care Behavioral Health (PCBH) With the Addition of Self-help CBT - A Randomized Multicenter Trial"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2021-06-14",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2026-12-31",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["Panic Disorder", "Social Anxiety Disorder", "Depression", "Hypochondriasis", "Insomnia", "Generalized Anxiety Disorder", "Burnout", "Adjustment Disorders", "Stress, Psychological", "Obsessive-Compulsive Disorder", "Life Stress", "Life Style Induced Illness", "Psychological Distress"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 1242,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT03414034",
          "briefTitle": "Onvansertib in Combination With Abiraterone and Prednisone in Adult Patients With Metastatic Castration-Resistant Prostate Cancer"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2018-08-14",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2023-10-16",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Metastatic Castration-Resistant Prostate Cancer"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 72,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "MALE",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT00536471",
          "briefTitle": "A Study Comparing Duloxetine and Placebo in Assessing Energy and Vitality in Major Depressive Disorder (MDD) Patients"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2007-09"
          },
          "completionDateStruct": {
            "date": "2008-12",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Major Depressive Disorder"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 776,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "65 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT02340975",
          "briefTitle": "A Phase 1b/2 Study of MEDI4736 With Tremelimumab, MEDI4736 or Tremelimumab Monotherapy in Gastric or GEJ Adenocarcinoma"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2015-03-31",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2019-04-29",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Gastric or Gastroesophageal Junction Adenocarcinoma"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 114,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "99 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT03880019",
          "briefTitle": "A Phase II Clinical Trial Evaluating the Combination of Olaparib and Temozolomide for the Treatment of Advanced Uterine Leiomyosarcoma"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2019-08-19",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2026-11-12",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["Stage III Uterine Corpus Leiomyosarcoma AJCC v8", "Stage IV Uterine Corpus Leiomyosarcoma AJCC v8", "Uterine Corpus Leiomyosarcoma"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 23,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "FEMALE",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT06399419",
          "briefTitle": "CBM588 Capsules in Combination With Nivolumab and Ipilimumab for the Treatment of Advanced Stage Kidney Cancer"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2024-06-19",
            "type": "ESTIMATED"
          },
          "completionDateStruct": {
            "date": "2026-10-19",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["Advanced Clear Cell Renal Cell Carcinoma", "Advanced Renal Cell Carcinoma", "Advanced Sarcomatoid Renal Cell Carcinoma", "Metastatic Clear Cell Renal Cell Carcinoma", "Metastatic Renal Cell Carcinoma", "Metastatic Sarcomatoid Renal Cell Carcinoma", "Stage III Renal Cell Cancer AJCC v8", "Stage IV Renal Cell Cancer AJCC v8"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 28,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT02721732",
          "briefTitle": "Pembrolizumab in Treating Patients With Rare Tumors That Cannot Be Removed by Surgery or Are Metastatic"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2016-08-15",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2025-12-31",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["Advanced Malignant Solid Neoplasm", "Carcinoma of Unknown Primary", "Metastatic Adrenal Gland Pheochromocytoma", "Metastatic Kidney Medullary Carcinoma", "Metastatic Malignant Germ Cell Tumor", "Metastatic Malignant Solid Neoplasm", "Metastatic Paraganglioma", "Metastatic Penile Carcinoma", "Metastatic Skin Squamous Cell Carcinoma", "Small Cell Carcinoma", "Stage III Adrenal Cortex Carcinoma AJCC v7", "Stage IV Adrenal Cortex Carcinoma AJCC v7", "Stage IV Penile Cancer AJCC v7", "Stage IV Renal Cell Cancer AJCC v7", "Unresectable Adrenal Gland Pheochromocytoma", "Unresectable Paraganglioma", "Unresectable Skin Squamous Cell Carcinoma", "Unresectable Solid Neoplasm", "Vascular Neoplasm"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 157,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT00863681",
          "briefTitle": "BAY63-2521:Long-term Extension Study in Patients With Pulmonary Arterial Hypertension"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2009-03-12",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2019-08-19",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Hypertension, Pulmonary"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 396,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "80 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT04375319",
          "briefTitle": "OCT Evaluation of Early Vascular Repair in Patients With Non ST Elevation Acute Coronary Syndrome (NSTE-ACS)"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2019-10-28",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2023-12-31",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["Unstable Anginas", "Non ST Segment Elevation Myocardial Infarction"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 60,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "80 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT02305407",
          "briefTitle": "Neurocognitive and Radiological Assessments in Adult Moyamoya Undergoing Surgery"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2016-03"
          },
          "completionDateStruct": {
            "date": "2018-05",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Moyamoya Disease"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 80,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": true,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "80 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT04157088",
          "briefTitle": "Study to Compare the Effects of Drug Darolutamide and Drug Enzalutamide on Physical Function, Including Balance and Daily Activity, in Patients With Castration-resistant Prostate Cancer (CRPC)"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2019-12-17",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2022-07-08",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Prostatic Cancer, Castration-Resistant"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 30,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "MALE",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT02354144",
          "briefTitle": "Lubricant Investigation in Men to Inhibit Transmission of HPV Infection"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2016-02",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2020-03-09",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Human Papillomavirus Infection"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 258,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": true,
          "sex": "MALE",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT03852498",
          "briefTitle": "A Clinical Study to Assess the Efficacy and Safety of Gene Therapy for the Treatment of Cerebral Adrenoleukodystrophy (CALD)"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2019-01-24",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2023-07-24",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Cerebral Adrenoleukodystrophy (CALD)"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 35,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "MALE",
          "maximumAge": "17 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT03994172",
          "briefTitle": "Novel Combination Therapy for Osteoporosis in Men"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2019-07-01",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2026-06-30",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Male Osteoporosis"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 40,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "MALE",
          "minimumAge": "60 Years",
          "maximumAge": "85 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT01890109",
          "briefTitle": "Study of Erenumab (AMG 334) in Women With Hot Flashes"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2013-05-13",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2014-03-11",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Vasomotor Symptoms; Hot Flashes"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 103,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "FEMALE",
          "minimumAge": "45 Years",
          "maximumAge": "65 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT01274507",
          "briefTitle": "A Study for Disease Profiling of Asthma and Chronic Obstructive Pulmonary Disease"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2010-07"
          },
          "completionDateStruct": {
            "date": "2014-07",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Asthma", "Pulmonary Disease, Chronic Obstructive"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 328,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "70 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT00372112",
          "briefTitle": "A Study To Assess The Safety And Tolerability Of GW642444 In Subjects With Chronic Obstructive Pulmonary Disease (COPD)"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2006-11-03",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2007-05-10",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Pulmonary Disease, Chronic Obstructive"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 68,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "40 Years",
          "maximumAge": "80 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT06609928",
          "briefTitle": "FH-FOLR1 Chimeric Antigen Receptor T Cell Therapy for Treating Pediatric Patients With Relapsed or Refractory Acute Myeloid Leukemia"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2025-02-24",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2042-10-01",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["Recurrent Childhood Acute Myeloid Leukemia", "Refractory Childhood Acute Myeloid Leukemia"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 12,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "maximumAge": "6 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT00549744",
          "briefTitle": "Clinical Endpoint Trial Investigating Once Daily and Bronchodilator Dosing"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2007-11-16",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2008-08-27",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Asthma"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 78,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "FEMALE",
          "minimumAge": "18 Years",
          "maximumAge": "65 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT02575807",
          "briefTitle": "Safety and Efficacy of CRS-207 With Epacadostat in Platinum Resistant Ovarian, Fallopian or Peritoneal Cancer"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2016-03-08",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2018-05-08",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Platinum-resistant Ovarian Cancer", "Platinum-resistant Fallopian Cancer", "Platinum-resistant Peritoneal Cancer"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 35,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "FEMALE",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT03961009",
          "briefTitle": "Clinical Assessment of Pharmacokinetics, Efficacy, and Safety of 10% IVIg in PID Patients"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2019-04-30",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2020-12-21",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Primary Immunodeficiency Disease"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 47,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "2 Years",
          "maximumAge": "70 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT00880230",
          "briefTitle": "Iliac Artery Treatment With The Invatec Scubaâ¢ Cobalt Chromium Stent (INTENSE)"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2009-03"
          },
          "completionDateStruct": {
            "date": "2012-12",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Peripheral Artery Disease"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 141,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT01141465",
          "briefTitle": "Real-world Effectiveness of Combination Therapy in Asthma"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2001-01"
          },
          "completionDateStruct": {
            "date": "2010-02",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Asthma"
        },
        "designModule": {
          "studyType": "OBSERVATIONAL",
          "enrollmentInfo": {
            "count": 815377,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "4 Years",
          "maximumAge": "80 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT04905992",
          "briefTitle": "Is a Single Daily Session Combining HS + Physio Sufficient to Obtain Long-term Clinical Benefits in Bronchiectasis?"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2021-07-01",
            "type": "ESTIMATED"
          },
          "completionDateStruct": {
            "date": "2023-12",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["Bronchiectasis", "Airway Clearance Impairment"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 50,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT03775434",
          "briefTitle": "A Study of B244 Delivered as a Topical Spray to Assess Safety in Pediatric Subjects With Atopic Dermatitis"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2018-12-07",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2019-06-10",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Eczema", "Atopic Dermatitis"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 28,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "2 Years",
          "maximumAge": "17 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT05656911",
          "briefTitle": "A Study to Learn How Well the Study Treatment Zabedosertib (BAY1834845) Works and How Safe it is Compared to Placebo in Adult Participants With Moderate-to-severe Atopic Dermatitis"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2022-12-21",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2024-01-31",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Atopic Dermatitis"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 77,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "65 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT04117100",
          "briefTitle": "Advanced Endo-therapeutic Procedure : Registry-based Observational Study"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2018-06-01",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2025-12-31",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["Zenker Diverticulum", "Polyp of Colon", "Colo-rectal Cancer"]
        },
        "designModule": {
          "studyType": "OBSERVATIONAL",
          "enrollmentInfo": {
            "count": 500,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT04832607",
          "briefTitle": "Multivirus-specific T-cell Transfer Post SCT vs AdV, CMV and EBV Infections"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2019-08-27",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2028-09",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["AdV Infection", "EBV Infection", "CMV Infection", "Stem Cell Transplant Complications"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 149,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "2 Months"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT06552234",
          "briefTitle": "Phase II Efficacy Study of Repotrectinib in Frail and/or Elderly Patients With ROS1-rearranged Advanced NSCLC"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2024-10-01",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2031-09",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["NSCLC Stage IV", "NSCLC, Stage III"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 30,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT01276314",
          "briefTitle": "Evaluation of TNF-Î± Blockade Effect in Patients With Severe Cutaneous Adverse Drug Reactions"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2009-01"
          },
          "completionDateStruct": {
            "date": "2015-05",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Drug Hypersensitivity"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 135,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "4 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT01727648",
          "briefTitle": "Effects of RAT in Sequential Combination With CIT in Stroke Rehabilitation"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2012-08"
          },
          "completionDateStruct": {
            "date": "2015-07",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Cerebrovascular Accident"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 92,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "20 Years",
          "maximumAge": "75 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT00401414",
          "briefTitle": "Study to Develop a Reliable Nomogram That Incorporates Clinical and Genetic Information"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2007-01"
          },
          "completionDateStruct": {
            "date": "2011-06",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Pulmonary Embolism", "Deep Vein Thrombosis", "Atrial Fibrillation"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 344,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT02688387",
          "briefTitle": "A Phase 1 Relative Bioavailability Study of Ambrisentan and Tadalfil Fixed Dose Combination Tablets in Healthy Subjects"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2016-03-18",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2017-08-04",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Hypertension, Pulmonary"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 112,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": true,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "60 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT04071405",
          "briefTitle": "Korea Post-marketing Surveillance for Xeljanz (Registered) in Ulcerative Colitis Patients"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2020-05-12",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2022-09-26",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Ulcerative Colitis"
        },
        "designModule": {
          "studyType": "OBSERVATIONAL",
          "enrollmentInfo": {
            "count": 110,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT02417753",
          "briefTitle": "AZD9150, a STAT3 Antisense Oligonucleotide, in People With Malignant Ascites"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2015-04-03",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2016-04-07",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Ovarian Cancer", "Ovarian Neoplasms", "Ascites", "Gastrointestinal Cancer", "Gastrointestinal Neoplasms"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 1,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "99 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT04201873",
          "briefTitle": "Pembrolizumab and a Vaccine (ATL-DC) for the Treatment of Surgically Accessible Recurrent Glioblastoma"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2020-01-08",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2027-08-01",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Recurrent Glioblastoma"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 40,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT05382494",
          "briefTitle": "Intranasal Steroid as Medical Therapy For Sleep-Disordered Breathing in Children"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2022-12-05",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2025-07-17",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Sleep Disorder; Breathing-Related", "Snoring", "Obstructive Sleep Apnea of Child", "Sleep Disorders in Children", "Tonsillar Hypertrophy", "Adenoidal Disorder"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 130,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "3 Years",
          "maximumAge": "12 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT03816956",
          "briefTitle": "Adjunctive Therapy to Antibiotics in the Treatment of S. Aureus Ventilator-Associated Pneumonia With AR-301"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2019-05-03",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2022-10-28",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Lung Infection", "Pneumonia, Ventilator-Associated", "Infection, Bacterial", "Staphylococcus Aureus"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 174,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT02982642",
          "briefTitle": "Efficacy and Safety of 1612 Capsules in aMnestic Mild Cognitive Impairment"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2017-01",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2018-12",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Mild Cognitive Impairment"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 0,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "55 Years",
          "maximumAge": "85 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT00005094",
          "briefTitle": "Celecoxib to Prevent Colorectal Cancer in Patients Who Have Undergone Surgery to Remove Polyps"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2000-03"
          },
          "completionDateStruct": {}
        },
        "conditionsModule": {
          "conditions": ["Colon Cancer", "Rectal Cancer"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 1170,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "30 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT07046286",
          "briefTitle": "Clinical Outcomes, Safety, and Cost-Effectiveness Analysis of Two Catheters (Xianrui Da and Medtronic) in Radiofrequency Ablation for Varicose Veins"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2025-08-01",
            "type": "ESTIMATED"
          },
          "completionDateStruct": {
            "date": "2026-10-01",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["Varicose Veins of Lower Limb", "Venous Insufficiency of Leg", "Vascular Diseaseï¼Peripheral"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 200,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "80 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT04076566",
          "briefTitle": "Malignant Ascites AlfapumpÂ® Study"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2020-05-31",
            "type": "ESTIMATED"
          },
          "completionDateStruct": {
            "date": "2022-03",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Malignant Ascites"
        },
        "designModule": {
          "studyType": "OBSERVATIONAL",
          "enrollmentInfo": {
            "count": 0,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT00162266",
          "briefTitle": "Abatacept With Methotrexate- Phase IIB"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2000-10"
          },
          "completionDateStruct": {
            "date": "2009-09",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Rheumatoid Arthritis"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 524,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT02044094",
          "briefTitle": "Multiple Dose Study of Blockade of Opioid Effects by Injections of Buprenorphine in Participants With Opioid Disorder"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2013-11"
          },
          "completionDateStruct": {
            "date": "2014-07",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Opioid Use Disorder"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 39,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "55 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT04803201",
          "briefTitle": "Testing the Addition of Duvelisib or CC-486 to the Usual Treatment for Peripheral T-Cell Lymphoma"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2021-10-08",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2026-06-30",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["Angioimmunoblastic T-cell Lymphoma", "Enteropathy-Associated T-Cell Lymphoma", "Follicular T-Cell Lymphoma", "Mature T-Cell and NK-Cell Non-Hodgkin Lymphoma", "Monomorphic Epitheliotropic Intestinal T-Cell Lymphoma", "Nodal Peripheral T-Cell Lymphoma With TFH Phenotype", "Peripheral T-Cell Lymphoma, Not Otherwise Specified"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 170,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT01510028",
          "briefTitle": "Multicenter Study of HGT-1110 Administered Intrathecally in Children With Metachromatic Leukodystrophy (MLD)"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2012-02-02",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2017-01-20",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Metachromatic Leukodystrophy (MLD)"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 24,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "maximumAge": "12 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT02921919",
          "briefTitle": "Open-Label Extension and Safety Study of Talazoparib"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2016-11-08",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2021-07-20",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Cancer"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 120,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT05507112",
          "briefTitle": "TIME in Immunotherapy Combined With nCRT for Rectal Cancer"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2022-09-20",
            "type": "ESTIMATED"
          },
          "completionDateStruct": {
            "date": "2029-12-01",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Locally Advanced Rectal Cancer"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 100,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "75 Years"
        }
      }
    ]
  }
}
